<!DOCTYPE html>
<html lang="en-US" prefix="og: http://ogp.me/ns#" >
<head>
	<script>
	  dataLayer = [];
	</script>
    
<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=0" />
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />
<meta name="format-detection" content="telephone=no">
<title>AMF Regulated Information - DBV Technologies</title>
<script type="text/javascript">var ajaxurl = "https://www.dbv-technologies.com/wp-admin/admin-ajax.php"</script><style id='theme-options-inline-styles' type='text/css'>body { background-color:#fff; } .mk-header { background-size:cover;-webkit-background-size:cover;-moz-background-size:cover; } .mk-header-bg { background-color:#ffffff; } .mk-classic-nav-bg { background-color:#ffffff; } .master-holder-bg { } #mk-footer { background-color:#d1d3d4; } #mk-boxed-layout { -webkit-box-shadow:0 0 0px rgba(0, 0, 0, 0); -moz-box-shadow:0 0 0px rgba(0, 0, 0, 0); box-shadow:0 0 0px rgba(0, 0, 0, 0); } .mk-news-tab .mk-tabs-tabs .is-active a, .mk-fancy-title.pattern-style span, .mk-fancy-title.pattern-style.color-gradient span:after, .page-bg-color { background-color:; } .page-title { font-size:20px; color:#4d4d4d; text-transform:uppercase; font-weight:400; letter-spacing:2px; } .page-subtitle { font-size:14px; line-height:100%; color:#a3a3a3; font-size:14px; text-transform:none; } .mk-header.sticky-style-fixed.a-sticky .mk-header-holder{ border-bottom:1px solid #8dd0d3; } .header-style-1 .mk-header-padding-wrapper, .header-style-2 .mk-header-padding-wrapper, .header-style-3 .mk-header-padding-wrapper { padding-top:136px; } @font-face { font-family:'star'; src:url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/star/font.eot'); src:url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/star/font.eot?#iefix') format('embedded-opentype'), url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/star/font.woff') format('woff'), url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/star/font.ttf') format('truetype'), url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/star/font.svg#star') format('svg'); font-weight:normal; font-style:normal; } @font-face { font-family:'WooCommerce'; src:url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/woocommerce/font.eot'); src:url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/woocommerce/font.eot?#iefix') format('embedded-opentype'), url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/woocommerce/font.woff') format('woff'), url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/woocommerce/font.ttf') format('truetype'), url('https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/fonts/woocommerce/font.svg#WooCommerce') format('svg'); font-weight:normal; font-style:normal; }.search-result-item { padding-top:0 !important; } .search-result-item .search-loop-meta>span { display:block !important; } .search #mk-breadcrumbs { dispaly:none; } .search .theme-content { margin-top: -50px; } .mk-search-loop .widget_search { display:none; } .search .theme-content { width:100% !important; } #tribe-events-header { display:none !important; } .mk-tweet-list.light li { background-color:transparent; border:none; } .mk-tweet-list.light li:first-child { border-bottom:1px solid rgba(255, 255, 255, 0.6); } #contact_info-2 ul li i { color:#fff; } .mk-tweet-list.light li:after { display:none; } .mk-tweet-list.light li:before { background:transparent; color:#fff !important; -webkit-text-fill-color:inherit; } .wpcf7 select, .wpcf7 .wpcf7-text { width:45%; display:inline-block; float:left; margin:10px 14px 10px 0; background-color:#f4fbfb !important; border:1px solid #e3e3e3; height:50px; } .wpcf7 select { margin-bottom:0; margin-top:30px!important; } .wpcf7-submit { background-color:#8cd0d3; color:#fff; border:none; margin-top:20px; padding:16px 25px; border-radius:0; } .wpcf7-submit:hover{ background-color:#72d5e7 } .mk-fancy-title.simple-style.color-single{ padding-bottom:0px!important; } @media only screen and (max-width:767px) { #top .avia-layerslider .ls-nav-prev, #top .avia-layerslider .ls-nav-next { display:none !important; } }</style><link rel="alternate" hreflang="en" href="https://www.dbv-technologies.com/investor-relations/financial-information/amf-regulated-information/" />
<link rel="alternate" hreflang="fr" href="https://www.dbv-technologies.com/fr/investor-relations/financial-information/amf-regulated-information/" />

		<style id="critical-path-css" type="text/css">
			body,html{width:100%;height:100%;margin:0;padding:0}.page-preloader{top:0;left:0;z-index:999;position:fixed;height:100%;width:100%;text-align:center}.preloader-preview-area{-webkit-animation-delay:-.2s;animation-delay:-.2s;top:50%;-webkit-transform:translateY(100%);-ms-transform:translateY(100%);transform:translateY(100%);margin-top:10px;max-height:calc(50% - 20px);opacity:1;width:100%;text-align:center;position:absolute}.preloader-logo{max-width:90%;top:50%;-webkit-transform:translateY(-100%);-ms-transform:translateY(-100%);transform:translateY(-100%);margin:-10px auto 0 auto;max-height:calc(50% - 20px);opacity:1;position:relative}.ball-pulse>div{width:15px;height:15px;border-radius:100%;margin:2px;-webkit-animation-fill-mode:both;animation-fill-mode:both;display:inline-block;-webkit-animation:ball-pulse .75s infinite cubic-bezier(.2,.68,.18,1.08);animation:ball-pulse .75s infinite cubic-bezier(.2,.68,.18,1.08)}.ball-pulse>div:nth-child(1){-webkit-animation-delay:-.36s;animation-delay:-.36s}.ball-pulse>div:nth-child(2){-webkit-animation-delay:-.24s;animation-delay:-.24s}.ball-pulse>div:nth-child(3){-webkit-animation-delay:-.12s;animation-delay:-.12s}@-webkit-keyframes ball-pulse{0%{-webkit-transform:scale(1);transform:scale(1);opacity:1}45%{-webkit-transform:scale(.1);transform:scale(.1);opacity:.7}80%{-webkit-transform:scale(1);transform:scale(1);opacity:1}}@keyframes ball-pulse{0%{-webkit-transform:scale(1);transform:scale(1);opacity:1}45%{-webkit-transform:scale(.1);transform:scale(.1);opacity:.7}80%{-webkit-transform:scale(1);transform:scale(1);opacity:1}}.ball-clip-rotate-pulse{position:relative;-webkit-transform:translateY(-15px) translateX(-10px);-ms-transform:translateY(-15px) translateX(-10px);transform:translateY(-15px) translateX(-10px);display:inline-block}.ball-clip-rotate-pulse>div{-webkit-animation-fill-mode:both;animation-fill-mode:both;position:absolute;top:0;left:0;border-radius:100%}.ball-clip-rotate-pulse>div:first-child{height:36px;width:36px;top:7px;left:-7px;-webkit-animation:ball-clip-rotate-pulse-scale 1s 0s cubic-bezier(.09,.57,.49,.9) infinite;animation:ball-clip-rotate-pulse-scale 1s 0s cubic-bezier(.09,.57,.49,.9) infinite}.ball-clip-rotate-pulse>div:last-child{position:absolute;width:50px;height:50px;left:-16px;top:-2px;background:0 0;border:2px solid;-webkit-animation:ball-clip-rotate-pulse-rotate 1s 0s cubic-bezier(.09,.57,.49,.9) infinite;animation:ball-clip-rotate-pulse-rotate 1s 0s cubic-bezier(.09,.57,.49,.9) infinite;-webkit-animation-duration:1s;animation-duration:1s}@-webkit-keyframes ball-clip-rotate-pulse-rotate{0%{-webkit-transform:rotate(0) scale(1);transform:rotate(0) scale(1)}50%{-webkit-transform:rotate(180deg) scale(.6);transform:rotate(180deg) scale(.6)}100%{-webkit-transform:rotate(360deg) scale(1);transform:rotate(360deg) scale(1)}}@keyframes ball-clip-rotate-pulse-rotate{0%{-webkit-transform:rotate(0) scale(1);transform:rotate(0) scale(1)}50%{-webkit-transform:rotate(180deg) scale(.6);transform:rotate(180deg) scale(.6)}100%{-webkit-transform:rotate(360deg) scale(1);transform:rotate(360deg) scale(1)}}@-webkit-keyframes ball-clip-rotate-pulse-scale{30%{-webkit-transform:scale(.3);transform:scale(.3)}100%{-webkit-transform:scale(1);transform:scale(1)}}@keyframes ball-clip-rotate-pulse-scale{30%{-webkit-transform:scale(.3);transform:scale(.3)}100%{-webkit-transform:scale(1);transform:scale(1)}}@-webkit-keyframes square-spin{25%{-webkit-transform:perspective(100px) rotateX(180deg) rotateY(0);transform:perspective(100px) rotateX(180deg) rotateY(0)}50%{-webkit-transform:perspective(100px) rotateX(180deg) rotateY(180deg);transform:perspective(100px) rotateX(180deg) rotateY(180deg)}75%{-webkit-transform:perspective(100px) rotateX(0) rotateY(180deg);transform:perspective(100px) rotateX(0) rotateY(180deg)}100%{-webkit-transform:perspective(100px) rotateX(0) rotateY(0);transform:perspective(100px) rotateX(0) rotateY(0)}}@keyframes square-spin{25%{-webkit-transform:perspective(100px) rotateX(180deg) rotateY(0);transform:perspective(100px) rotateX(180deg) rotateY(0)}50%{-webkit-transform:perspective(100px) rotateX(180deg) rotateY(180deg);transform:perspective(100px) rotateX(180deg) rotateY(180deg)}75%{-webkit-transform:perspective(100px) rotateX(0) rotateY(180deg);transform:perspective(100px) rotateX(0) rotateY(180deg)}100%{-webkit-transform:perspective(100px) rotateX(0) rotateY(0);transform:perspective(100px) rotateX(0) rotateY(0)}}.square-spin{display:inline-block}.square-spin>div{-webkit-animation-fill-mode:both;animation-fill-mode:both;width:50px;height:50px;-webkit-animation:square-spin 3s 0s cubic-bezier(.09,.57,.49,.9) infinite;animation:square-spin 3s 0s cubic-bezier(.09,.57,.49,.9) infinite}.cube-transition{position:relative;-webkit-transform:translate(-25px,-25px);-ms-transform:translate(-25px,-25px);transform:translate(-25px,-25px);display:inline-block}.cube-transition>div{-webkit-animation-fill-mode:both;animation-fill-mode:both;width:15px;height:15px;position:absolute;top:-5px;left:-5px;-webkit-animation:cube-transition 1.6s 0s infinite ease-in-out;animation:cube-transition 1.6s 0s infinite ease-in-out}.cube-transition>div:last-child{-webkit-animation-delay:-.8s;animation-delay:-.8s}@-webkit-keyframes cube-transition{25%{-webkit-transform:translateX(50px) scale(.5) rotate(-90deg);transform:translateX(50px) scale(.5) rotate(-90deg)}50%{-webkit-transform:translate(50px,50px) rotate(-180deg);transform:translate(50px,50px) rotate(-180deg)}75%{-webkit-transform:translateY(50px) scale(.5) rotate(-270deg);transform:translateY(50px) scale(.5) rotate(-270deg)}100%{-webkit-transform:rotate(-360deg);transform:rotate(-360deg)}}@keyframes cube-transition{25%{-webkit-transform:translateX(50px) scale(.5) rotate(-90deg);transform:translateX(50px) scale(.5) rotate(-90deg)}50%{-webkit-transform:translate(50px,50px) rotate(-180deg);transform:translate(50px,50px) rotate(-180deg)}75%{-webkit-transform:translateY(50px) scale(.5) rotate(-270deg);transform:translateY(50px) scale(.5) rotate(-270deg)}100%{-webkit-transform:rotate(-360deg);transform:rotate(-360deg)}}.ball-scale>div{border-radius:100%;margin:2px;-webkit-animation-fill-mode:both;animation-fill-mode:both;display:inline-block;height:60px;width:60px;-webkit-animation:ball-scale 1s 0s ease-in-out infinite;animation:ball-scale 1s 0s ease-in-out infinite}@-webkit-keyframes ball-scale{0%{-webkit-transform:scale(0);transform:scale(0)}100%{-webkit-transform:scale(1);transform:scale(1);opacity:0}}@keyframes ball-scale{0%{-webkit-transform:scale(0);transform:scale(0)}100%{-webkit-transform:scale(1);transform:scale(1);opacity:0}}.line-scale>div{-webkit-animation-fill-mode:both;animation-fill-mode:both;display:inline-block;width:5px;height:50px;border-radius:2px;margin:2px}.line-scale>div:nth-child(1){-webkit-animation:line-scale 1s -.5s infinite cubic-bezier(.2,.68,.18,1.08);animation:line-scale 1s -.5s infinite cubic-bezier(.2,.68,.18,1.08)}.line-scale>div:nth-child(2){-webkit-animation:line-scale 1s -.4s infinite cubic-bezier(.2,.68,.18,1.08);animation:line-scale 1s -.4s infinite cubic-bezier(.2,.68,.18,1.08)}.line-scale>div:nth-child(3){-webkit-animation:line-scale 1s -.3s infinite cubic-bezier(.2,.68,.18,1.08);animation:line-scale 1s -.3s infinite cubic-bezier(.2,.68,.18,1.08)}.line-scale>div:nth-child(4){-webkit-animation:line-scale 1s -.2s infinite cubic-bezier(.2,.68,.18,1.08);animation:line-scale 1s -.2s infinite cubic-bezier(.2,.68,.18,1.08)}.line-scale>div:nth-child(5){-webkit-animation:line-scale 1s -.1s infinite cubic-bezier(.2,.68,.18,1.08);animation:line-scale 1s -.1s infinite cubic-bezier(.2,.68,.18,1.08)}@-webkit-keyframes line-scale{0%{-webkit-transform:scaley(1);transform:scaley(1)}50%{-webkit-transform:scaley(.4);transform:scaley(.4)}100%{-webkit-transform:scaley(1);transform:scaley(1)}}@keyframes line-scale{0%{-webkit-transform:scaley(1);transform:scaley(1)}50%{-webkit-transform:scaley(.4);transform:scaley(.4)}100%{-webkit-transform:scaley(1);transform:scaley(1)}}.ball-scale-multiple{position:relative;-webkit-transform:translateY(30px);-ms-transform:translateY(30px);transform:translateY(30px);display:inline-block}.ball-scale-multiple>div{border-radius:100%;-webkit-animation-fill-mode:both;animation-fill-mode:both;margin:2px;position:absolute;left:-30px;top:0;opacity:0;margin:0;width:50px;height:50px;-webkit-animation:ball-scale-multiple 1s 0s linear infinite;animation:ball-scale-multiple 1s 0s linear infinite}.ball-scale-multiple>div:nth-child(2){-webkit-animation-delay:-.2s;animation-delay:-.2s}.ball-scale-multiple>div:nth-child(3){-webkit-animation-delay:-.2s;animation-delay:-.2s}@-webkit-keyframes ball-scale-multiple{0%{-webkit-transform:scale(0);transform:scale(0);opacity:0}5%{opacity:1}100%{-webkit-transform:scale(1);transform:scale(1);opacity:0}}@keyframes ball-scale-multiple{0%{-webkit-transform:scale(0);transform:scale(0);opacity:0}5%{opacity:1}100%{-webkit-transform:scale(1);transform:scale(1);opacity:0}}.ball-pulse-sync{display:inline-block}.ball-pulse-sync>div{width:15px;height:15px;border-radius:100%;margin:2px;-webkit-animation-fill-mode:both;animation-fill-mode:both;display:inline-block}.ball-pulse-sync>div:nth-child(1){-webkit-animation:ball-pulse-sync .6s -.21s infinite ease-in-out;animation:ball-pulse-sync .6s -.21s infinite ease-in-out}.ball-pulse-sync>div:nth-child(2){-webkit-animation:ball-pulse-sync .6s -.14s infinite ease-in-out;animation:ball-pulse-sync .6s -.14s infinite ease-in-out}.ball-pulse-sync>div:nth-child(3){-webkit-animation:ball-pulse-sync .6s -70ms infinite ease-in-out;animation:ball-pulse-sync .6s -70ms infinite ease-in-out}@-webkit-keyframes ball-pulse-sync{33%{-webkit-transform:translateY(10px);transform:translateY(10px)}66%{-webkit-transform:translateY(-10px);transform:translateY(-10px)}100%{-webkit-transform:translateY(0);transform:translateY(0)}}@keyframes ball-pulse-sync{33%{-webkit-transform:translateY(10px);transform:translateY(10px)}66%{-webkit-transform:translateY(-10px);transform:translateY(-10px)}100%{-webkit-transform:translateY(0);transform:translateY(0)}}.transparent-circle{display:inline-block;border-top:.5em solid rgba(255,255,255,.2);border-right:.5em solid rgba(255,255,255,.2);border-bottom:.5em solid rgba(255,255,255,.2);border-left:.5em solid #fff;-webkit-transform:translateZ(0);transform:translateZ(0);-webkit-animation:transparent-circle 1.1s infinite linear;animation:transparent-circle 1.1s infinite linear;width:50px;height:50px;border-radius:50%}.transparent-circle:after{border-radius:50%;width:10em;height:10em}@-webkit-keyframes transparent-circle{0%{-webkit-transform:rotate(0);transform:rotate(0)}100%{-webkit-transform:rotate(360deg);transform:rotate(360deg)}}@keyframes transparent-circle{0%{-webkit-transform:rotate(0);transform:rotate(0)}100%{-webkit-transform:rotate(360deg);transform:rotate(360deg)}}.ball-spin-fade-loader{position:relative;top:-10px;left:-10px;display:inline-block}.ball-spin-fade-loader>div{width:15px;height:15px;border-radius:100%;margin:2px;-webkit-animation-fill-mode:both;animation-fill-mode:both;position:absolute;-webkit-animation:ball-spin-fade-loader 1s infinite linear;animation:ball-spin-fade-loader 1s infinite linear}.ball-spin-fade-loader>div:nth-child(1){top:25px;left:0;animation-delay:-.84s;-webkit-animation-delay:-.84s}.ball-spin-fade-loader>div:nth-child(2){top:17.05px;left:17.05px;animation-delay:-.72s;-webkit-animation-delay:-.72s}.ball-spin-fade-loader>div:nth-child(3){top:0;left:25px;animation-delay:-.6s;-webkit-animation-delay:-.6s}.ball-spin-fade-loader>div:nth-child(4){top:-17.05px;left:17.05px;animation-delay:-.48s;-webkit-animation-delay:-.48s}.ball-spin-fade-loader>div:nth-child(5){top:-25px;left:0;animation-delay:-.36s;-webkit-animation-delay:-.36s}.ball-spin-fade-loader>div:nth-child(6){top:-17.05px;left:-17.05px;animation-delay:-.24s;-webkit-animation-delay:-.24s}.ball-spin-fade-loader>div:nth-child(7){top:0;left:-25px;animation-delay:-.12s;-webkit-animation-delay:-.12s}.ball-spin-fade-loader>div:nth-child(8){top:17.05px;left:-17.05px;animation-delay:0s;-webkit-animation-delay:0s}@-webkit-keyframes ball-spin-fade-loader{50%{opacity:.3;-webkit-transform:scale(.4);transform:scale(.4)}100%{opacity:1;-webkit-transform:scale(1);transform:scale(1)}}@keyframes ball-spin-fade-loader{50%{opacity:.3;-webkit-transform:scale(.4);transform:scale(.4)}100%{opacity:1;-webkit-transform:scale(1);transform:scale(1)}}		</style>

		
<!-- This site is optimized with the Yoast SEO plugin v7.9 - https://yoast.com/wordpress/plugins/seo/ -->
<link rel="canonical" href="https://www.dbv-technologies.com/investor-relations/financial-information/amf-regulated-information/" />
<meta property="og:locale" content="en_US" />
<meta property="og:type" content="article" />
<meta property="og:title" content="AMF Regulated Information - DBV Technologies" />
<meta property="og:url" content="https://www.dbv-technologies.com/investor-relations/financial-information/amf-regulated-information/" />
<meta property="og:site_name" content="DBV Technologies" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:title" content="AMF Regulated Information - DBV Technologies" />
<!-- / Yoast SEO plugin. -->

<link rel='dns-prefetch' href='//cdn.datatables.net' />
<link rel='dns-prefetch' href='//s.w.org' />
<link rel="alternate" type="application/rss+xml" title="DBV Technologies &raquo; Feed" href="https://www.dbv-technologies.com/feed/" />
<link rel="alternate" type="application/rss+xml" title="DBV Technologies &raquo; Comments Feed" href="https://www.dbv-technologies.com/comments/feed/" />
<link rel="alternate" type="text/calendar" title="DBV Technologies &raquo; iCal Feed" href="https://www.dbv-technologies.com/events/?ical=1" />

<link rel="shortcut icon" href="https://www.dbv-technologies.com/wp-content/uploads/2017/08/favicon.gif"  />
<script type="text/javascript">
window.abb = {};
php = {};
window.PHP = {};
PHP.ajax = "https://www.dbv-technologies.com/wp-admin/admin-ajax.php";PHP.wp_p_id = "5038";var mk_header_parallax, mk_banner_parallax, mk_page_parallax, mk_footer_parallax, mk_body_parallax;
var mk_images_dir = "https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/images",
mk_theme_js_path = "https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/js",
mk_theme_dir = "https://www.dbv-technologies.com/wp-content/themes/jupiter",
mk_captcha_placeholder = "Enter Captcha",
mk_captcha_invalid_txt = "Invalid. Try again.",
mk_captcha_correct_txt = "Captcha correct.",
mk_responsive_nav_width = 1140,
mk_vertical_header_back = "Back",
mk_vertical_header_anim = "1",
mk_check_rtl = true,
mk_grid_width = 960,
mk_ajax_search_option = "toolbar",
mk_preloader_bg_color = "#ffffff",
mk_accent_color = "#f26922",
mk_go_to_top =  "true",
mk_smooth_scroll =  "true",
mk_preloader_bar_color = "#f26922",
mk_preloader_logo = "";
var mk_header_parallax = false,
mk_banner_parallax = false,
mk_footer_parallax = false,
mk_body_parallax = false,
mk_no_more_posts = "No More Posts",
mk_typekit_id   = "",
mk_google_fonts = ["Open Sans:100italic,200italic,300italic,400italic,500italic,600italic,700italic,800italic,900italic,100,200,300,400,500,600,700,800,900","Open Sans:100italic,200italic,300italic,400italic,500italic,600italic,700italic,800italic,900italic,100,200,300,400,500,600,700,800,900","Open Sans:100italic,200italic,300italic,400italic,500italic,600italic,700italic,800italic,900italic,100,200,300,400,500,600,700,800,900"],
mk_global_lazyload = true;
</script>
<link rel='stylesheet' id='chartstyle-css'  href='https://www.dbv-technologies.com/wp-content/plugins/b2i-investor-tools/css/style.css?ver=0.8.3' type='text/css' media='' />
<link rel='stylesheet' id='export-css'  href='https://www.dbv-technologies.com/wp-content/plugins/b2i-investor-tools/css/export.css?ver=0.8.3' type='text/css' media='' />
<link rel='stylesheet' id='layerslider-css'  href='https://www.dbv-technologies.com/wp-content/plugins/LayerSlider/static/layerslider/css/layerslider.css?ver=6.7.0' type='text/css' media='all' />
<link rel='stylesheet' id='wpml-legacy-horizontal-list-0-css'  href='//www.dbv-technologies.com/wp-content/plugins/sitepress-multilingual-cms/templates/language-switchers/legacy-list-horizontal/style.css?ver=1' type='text/css' media='all' />
<link rel='stylesheet' id='dbv-styles-css'  href='https://www.dbv-technologies.com/wp-content/themes/jupiter-child/css/dbv.css?ver=4.9.12' type='text/css' media='all' />
<link rel='stylesheet' id='datatables-style-css'  href='//cdn.datatables.net/1.10.12/css/jquery.dataTables.min.css?ver=4.9.12' type='text/css' media='all' />
<link rel='stylesheet' id='theme-styles-css'  href='https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/stylesheet/min/full-styles.css?ver=4.9.12' type='text/css' media='all' />
<link rel='stylesheet' id='js_composer_front-css'  href='https://www.dbv-technologies.com/wp-content/plugins/js_composer_theme/assets/css/js_composer.min.css?ver=5.1.1' type='text/css' media='all' />
<link rel='stylesheet' id='theme-options-css'  href='https://www.dbv-technologies.com/wp-content/uploads/mk_assets/theme-options-production.css?ver=1537557362' type='text/css' media='all' />
<link rel='stylesheet' id='mk-style-css'  href='https://www.dbv-technologies.com/wp-content/themes/jupiter-child/style.css?ver=4.9.12' type='text/css' media='all' />
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-includes/js/jquery/jquery.js?ver=1.12.4'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/b2i-investor-tools/js/wb_script.js?ver=0.8.3'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/b2i-investor-tools/js/amcharts.js?ver=0.8.3'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/b2i-investor-tools/js/serial.js?ver=0.8.3'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/b2i-investor-tools/js/amstock.js?ver=0.8.3'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/b2i-investor-tools/js/export.js?ver=0.8.3'></script>
<script type='text/javascript'>
/* <![CDATA[ */
var LS_Meta = {"v":"6.7.0"};
/* ]]> */
</script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/LayerSlider/static/layerslider/js/greensock.js?ver=1.19.0'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/LayerSlider/static/layerslider/js/layerslider.kreaturamedia.jquery.js?ver=6.7.0'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/LayerSlider/static/layerslider/js/layerslider.transitions.js?ver=6.7.0'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/themes/jupiter-child/js/scripts.js?ver=4.9.12'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/js/plugins/wp-enqueue/webfontloader.js?ver=4.9.12'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/js/plugins/wp-enqueue/webfontloader-init.js?ver=4.9.12'></script>
<meta name="generator" content="Powered by LayerSlider 6.7.0 - Multi-Purpose, Responsive, Parallax, Mobile-Friendly Slider Plugin for WordPress." />
<!-- LayerSlider updates and docs at: https://layerslider.kreaturamedia.com -->
<link rel='https://api.w.org/' href='https://www.dbv-technologies.com/wp-json/' />
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="https://www.dbv-technologies.com/xmlrpc.php?rsd" />
<link rel="wlwmanifest" type="application/wlwmanifest+xml" href="https://www.dbv-technologies.com/wp-includes/wlwmanifest.xml" /> 
<meta name="generator" content="WordPress 4.9.12" />
<link rel='shortlink' href='https://www.dbv-technologies.com/?p=5038' />
<link rel="alternate" type="application/json+oembed" href="https://www.dbv-technologies.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.dbv-technologies.com%2Finvestor-relations%2Ffinancial-information%2Famf-regulated-information%2F" />
<link rel="alternate" type="text/xml+oembed" href="https://www.dbv-technologies.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fwww.dbv-technologies.com%2Finvestor-relations%2Ffinancial-information%2Famf-regulated-information%2F&#038;format=xml" />
<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-T88GSVZ');</script>
<!-- End Google Tag Manager --><meta name="generator" content="WPML ver:3.9.1 stt:1,4;" />
<meta name="tec-api-version" content="v1"><meta name="tec-api-origin" content="https://www.dbv-technologies.com"><link rel="https://theeventscalendar.com/" href="https://www.dbv-technologies.com/wp-json/tribe/events/v1/" /><script> var isTest = false; </script>
<style id="js-media-query-css">.mk-event-countdown-ul:media(max-width:750px) li{width:90%;display:block;margin:0 auto 15px}.mk-process-steps:media(max-width:960px) ul:before{display:none!important}.mk-process-steps:media(max-width:960px) li{margin-bottom:30px!important;width:100%!important;text-align:center}</style><meta itemprop="author" content="DBV Technologies" /><meta itemprop="datePublished" content="August 3, 2017" /><meta itemprop="dateModified" content="January 22, 2018" /><meta itemprop="publisher" content="DBV Technologies" />		<style type="text/css">.recentcomments a{display:inline !important;padding:0 !important;margin:0 !important;}</style>
		<meta name="generator" content="Powered by Visual Composer - drag and drop page builder for WordPress."/>
<!--[if lte IE 9]><link rel="stylesheet" type="text/css" href="https://www.dbv-technologies.com/wp-content/plugins/js_composer_theme/assets/css/vc_lte_ie9.min.css" media="screen"><![endif]-->		<style type="text/css" id="wp-custom-css">
			/*
You can add your own CSS here.

Click the help icon above to learn more.
*/

		</style>
	<meta name="generator" content="DBV (Jupiter Child) " />
<style type="text/css" data-type="vc_shortcodes-custom-css">.vc_custom_1516659497263{padding-top: 30px !important;}.vc_custom_1503427678329{padding-left: 60px !important;}</style><noscript><style type="text/css"> .wpb_animate_when_almost_visible { opacity: 1; }</style></noscript></head>

<body class="page-template-default page page-id-5038 page-child parent-pageid-5510 loading tribe-no-js tribe-bar-is-disabled wpb-js-composer js-comp-ver-5.1.1 vc_responsive" itemscope="itemscope" itemtype="https://schema.org/WebPage"  data-adminbar="">
	<!-- Google Tag Manager (noscript) -->
	<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T88GSVZ" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
	<!-- End Google Tag Manager (noscript) -->

	<div class="mk-body-loader-overlay page-preloader" style="background-color:#ffffff;"> <div class="preloader-preview-area">  <div class="ball-pulse">
                            <div style="background-color: #ffffff"></div>
                            <div style="background-color: #ffffff"></div>
                            <div style="background-color: #ffffff"></div>
                        </div>  </div></div>
	<!-- Target for scroll anchors to achieve native browser bahaviour + possible enhancements like smooth scrolling -->
	<div id="top-of-page"></div>

		<div id="mk-boxed-layout">

			<div id="mk-theme-container" >

				 
    <header data-height='100'
                data-sticky-height='55'
                data-responsive-height='90'
                data-transparent-skin=''
                data-header-style='1'
                data-sticky-style='fixed'
                data-sticky-offset='header' id="mk-header-1" class="mk-header header-style-1 header-align-left  toolbar-true menu-hover-5 sticky-style-fixed mk-background-stretch full-header " role="banner" itemscope="itemscope" itemtype="https://schema.org/WPHeader" >
                    <div class="mk-header-holder">
                
<div class="mk-header-toolbar">

	
		<div class="mk-toolbar-holder">

		<div class="mk-language-nav"><a href="#"><svg  class="mk-svg-icon" data-name="mk-icon-globe" data-cacheid="icon-5dde4defb5c84" style=" height:16px; width: 13.714285714286px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1536 1792"><path d="M768 128q209 0 385.5 103t279.5 279.5 103 385.5-103 385.5-279.5 279.5-385.5 103-385.5-103-279.5-279.5-103-385.5 103-385.5 279.5-279.5 385.5-103zm274 521q-2 1-9.5 9.5t-13.5 9.5q2 0 4.5-5t5-11 3.5-7q6-7 22-15 14-6 52-12 34-8 51 11-2-2 9.5-13t14.5-12q3-2 15-4.5t15-7.5l2-22q-12 1-17.5-7t-6.5-21q0 2-6 8 0-7-4.5-8t-11.5 1-9 1q-10-3-15-7.5t-8-16.5-4-15q-2-5-9.5-10.5t-9.5-10.5q-1-2-2.5-5.5t-3-6.5-4-5.5-5.5-2.5-7 5-7.5 10-4.5 5q-3-2-6-1.5t-4.5 1-4.5 3-5 3.5q-3 2-8.5 3t-8.5 2q15-5-1-11-10-4-16-3 9-4 7.5-12t-8.5-14h5q-1-4-8.5-8.5t-17.5-8.5-13-6q-8-5-34-9.5t-33-.5q-5 6-4.5 10.5t4 14 3.5 12.5q1 6-5.5 13t-6.5 12q0 7 14 15.5t10 21.5q-3 8-16 16t-16 12q-5 8-1.5 18.5t10.5 16.5q2 2 1.5 4t-3.5 4.5-5.5 4-6.5 3.5l-3 2q-11 5-20.5-6t-13.5-26q-7-25-16-30-23-8-29 1-5-13-41-26-25-9-58-4 6-1 0-15-7-15-19-12 3-6 4-17.5t1-13.5q3-13 12-23 1-1 7-8.5t9.5-13.5.5-6q35 4 50-11 5-5 11.5-17t10.5-17q9-6 14-5.5t14.5 5.5 14.5 5q14 1 15.5-11t-7.5-20q12 1 3-17-5-7-8-9-12-4-27 5-8 4 2 8-1-1-9.5 10.5t-16.5 17.5-16-5q-1-1-5.5-13.5t-9.5-13.5q-8 0-16 15 3-8-11-15t-24-8q19-12-8-27-7-4-20.5-5t-19.5 4q-5 7-5.5 11.5t5 8 10.5 5.5 11.5 4 8.5 3q14 10 8 14-2 1-8.5 3.5t-11.5 4.5-6 4q-3 4 0 14t-2 14q-5-5-9-17.5t-7-16.5q7 9-25 6l-10-1q-4 0-16 2t-20.5 1-13.5-8q-4-8 0-20 1-4 4-2-4-3-11-9.5t-10-8.5q-46 15-94 41 6 1 12-1 5-2 13-6.5t10-5.5q34-14 42-7l5-5q14 16 20 25-7-4-30-1-20 6-22 12 7 12 5 18-4-3-11.5-10t-14.5-11-15-5q-16 0-22 1-146 80-235 222 7 7 12 8 4 1 5 9t2.5 11 11.5-3q9 8 3 19 1-1 44 27 19 17 21 21 3 11-10 18-1-2-9-9t-9-4q-3 5 .5 18.5t10.5 12.5q-7 0-9.5 16t-2.5 35.5-1 23.5l2 1q-3 12 5.5 34.5t21.5 19.5q-13 3 20 43 6 8 8 9 3 2 12 7.5t15 10 10 10.5q4 5 10 22.5t14 23.5q-2 6 9.5 20t10.5 23q-1 0-2.5 1t-2.5 1q3 7 15.5 14t15.5 13q1 3 2 10t3 11 8 2q2-20-24-62-15-25-17-29-3-5-5.5-15.5t-4.5-14.5q2 0 6 1.5t8.5 3.5 7.5 4 2 3q-3 7 2 17.5t12 18.5 17 19 12 13q6 6 14 19.5t0 13.5q9 0 20 10t17 20q5 8 8 26t5 24q2 7 8.5 13.5t12.5 9.5l16 8 13 7q5 2 18.5 10.5t21.5 11.5q10 4 16 4t14.5-2.5 13.5-3.5q15-2 29 15t21 21q36 19 55 11-2 1 .5 7.5t8 15.5 9 14.5 5.5 8.5q5 6 18 15t18 15q6-4 7-9-3 8 7 20t18 10q14-3 14-32-31 15-49-18 0-1-2.5-5.5t-4-8.5-2.5-8.5 0-7.5 5-3q9 0 10-3.5t-2-12.5-4-13q-1-8-11-20t-12-15q-5 9-16 8t-16-9q0 1-1.5 5.5t-1.5 6.5q-13 0-15-1 1-3 2.5-17.5t3.5-22.5q1-4 5.5-12t7.5-14.5 4-12.5-4.5-9.5-17.5-2.5q-19 1-26 20-1 3-3 10.5t-5 11.5-9 7q-7 3-24 2t-24-5q-13-8-22.5-29t-9.5-37q0-10 2.5-26.5t3-25-5.5-24.5q3-2 9-9.5t10-10.5q2-1 4.5-1.5t4.5 0 4-1.5 3-6q-1-1-4-3-3-3-4-3 7 3 28.5-1.5t27.5 1.5q15 11 22-2 0-1-2.5-9.5t-.5-13.5q5 27 29 9 3 3 15.5 5t17.5 5q3 2 7 5.5t5.5 4.5 5-.5 8.5-6.5q10 14 12 24 11 40 19 44 7 3 11 2t4.5-9.5 0-14-1.5-12.5l-1-8v-18l-1-8q-15-3-18.5-12t1.5-18.5 15-18.5q1-1 8-3.5t15.5-6.5 12.5-8q21-19 15-35 7 0 11-9-1 0-5-3t-7.5-5-4.5-2q9-5 2-16 5-3 7.5-11t7.5-10q9 12 21 2 7-8 1-16 5-7 20.5-10.5t18.5-9.5q7 2 8-2t1-12 3-12q4-5 15-9t13-5l17-11q3-4 0-4 18 2 31-11 10-11-6-20 3-6-3-9.5t-15-5.5q3-1 11.5-.5t10.5-1.5q15-10-7-16-17-5-43 12zm-163 877q206-36 351-189-3-3-12.5-4.5t-12.5-3.5q-18-7-24-8 1-7-2.5-13t-8-9-12.5-8-11-7q-2-2-7-6t-7-5.5-7.5-4.5-8.5-2-10 1l-3 1q-3 1-5.5 2.5t-5.5 3-4 3 0 2.5q-21-17-36-22-5-1-11-5.5t-10.5-7-10-1.5-11.5 7q-5 5-6 15t-2 13q-7-5 0-17.5t2-18.5q-3-6-10.5-4.5t-12 4.5-11.5 8.5-9 6.5-8.5 5.5-8.5 7.5q-3 4-6 12t-5 11q-2-4-11.5-6.5t-9.5-5.5q2 10 4 35t5 38q7 31-12 48-27 25-29 40-4 22 12 26 0 7-8 20.5t-7 21.5q0 6 2 16z"/></svg>Languages</a><div class="mk-language-nav-sub-wrapper"><div class="mk-language-nav-sub"><ul class='mk-language-navigation'><li class='language_fr'><a href='https://www.dbv-technologies.com/fr/investor-relations/financial-information/amf-regulated-information/'><span class='mk-lang-flag'><img title='Français' src='https://www.dbv-technologies.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/fr.png' /></span><span class='mk-lang-name'>Français</span></a></li><li class='language_en'><a href='https://www.dbv-technologies.com/investor-relations/financial-information/amf-regulated-information/'><span class='mk-lang-flag'><img title='English' src='https://www.dbv-technologies.com/wp-content/plugins/sitepress-multilingual-cms/res/flags/en.png' /></span><span class='mk-lang-name'>English</span></a></li></ul></div></div></div>
<div class="mk-header-search">
    <form class="mk-header-searchform" method="get" id="mk-header-searchform" action="https://www.dbv-technologies.com/">
        <span>
        	<input type="text" class="text-input on-close-state" value="" name="s" id="s" placeholder="Search.." />
        	<i class="mk-searchform-icon"><svg  class="mk-svg-icon" data-name="mk-icon-search" data-cacheid="icon-5dde4defb60b3" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1664 1792"><path d="M1152 832q0-185-131.5-316.5t-316.5-131.5-316.5 131.5-131.5 316.5 131.5 316.5 316.5 131.5 316.5-131.5 131.5-316.5zm512 832q0 52-38 90t-90 38q-54 0-90-38l-343-342q-179 124-399 124-143 0-273.5-55.5t-225-150-150-225-55.5-273.5 55.5-273.5 150-225 225-150 273.5-55.5 273.5 55.5 225 150 150 225 55.5 273.5q0 220-124 399l343 343q37 37 37 90z"/></svg><input value="" type="submit" class="header-search-btn" /></i>
        </span>
    </form>
</div>
<div class="mk-header-social toolbar-section"><ul><li><a class="facebook-hover " target="_blank" href="https://www.facebook.com/DBV-Technologies-222890957906209/timeline/"><svg  class="mk-svg-icon" data-name="mk-jupiter-icon-simple-facebook" data-cacheid="icon-5dde4defb62c3" style=" height:16px; width: 16px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M192.191 92.743v60.485h-63.638v96.181h63.637v256.135h97.069v-256.135h84.168s6.674-51.322 9.885-96.508h-93.666v-42.921c0-8.807 11.565-20.661 23.01-20.661h71.791v-95.719h-83.57c-111.317 0-108.686 86.262-108.686 99.142z"/></svg></i></a></li><li><a class="twitter-hover " target="_blank" href="https://twitter.com/dbvtechnologies"><svg  class="mk-svg-icon" data-name="mk-jupiter-icon-simple-twitter" data-cacheid="icon-5dde4defb6464" style=" height:16px; width: 16px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M454.058 213.822c28.724-2.382 48.193-15.423 55.683-33.132-10.365 6.373-42.524 13.301-60.269 6.681-.877-4.162-1.835-8.132-2.792-11.706-13.527-49.679-59.846-89.698-108.382-84.865 3.916-1.589 7.914-3.053 11.885-4.388 5.325-1.923 36.678-7.003 31.749-18.079-4.176-9.728-42.471 7.352-49.672 9.597 9.501-3.581 25.26-9.735 26.93-20.667-14.569 1.991-28.901 8.885-39.937 18.908 3.998-4.293 7.01-9.536 7.666-15.171-38.91 24.85-61.624 74.932-80.025 123.523-14.438-13.972-27.239-25.008-38.712-31.114-32.209-17.285-70.722-35.303-131.156-57.736-1.862 19.996 9.899 46.591 43.723 64.273-7.325-.986-20.736 1.219-31.462 3.773 4.382 22.912 18.627 41.805 57.251 50.918-17.642 1.163-26.767 5.182-35.036 13.841 8.043 15.923 27.656 34.709 62.931 30.82-39.225 16.935-15.998 48.234 15.93 43.565-54.444 56.244-140.294 52.123-189.596 5.08 128.712 175.385 408.493 103.724 450.21-65.225 31.23.261 49.605-10.823 60.994-23.05-17.99 3.053-44.072-.095-57.914-5.846z"/></svg></i></a></li><li><a class="linkedin-hover " target="_blank" href="https://www.linkedin.com/company/dbv-technologies"><svg  class="mk-svg-icon" data-name="mk-jupiter-icon-simple-linkedin" data-cacheid="icon-5dde4defb6640" style=" height:16px; width: 16px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M80.111 25.6c-29.028 0-48.023 20.547-48.023 47.545 0 26.424 18.459 47.584 46.893 47.584h.573c29.601 0 47.999-21.16 47.999-47.584-.543-26.998-18.398-47.545-47.442-47.545zm-48.111 128h96v320.99h-96v-320.99zm323.631-7.822c-58.274 0-84.318 32.947-98.883 55.996v1.094h-.726c.211-.357.485-.713.726-1.094v-48.031h-96.748c1.477 31.819 0 320.847 0 320.847h96.748v-171.241c0-10.129.742-20.207 3.633-27.468 7.928-20.224 25.965-41.185 56.305-41.185 39.705 0 67.576 31.057 67.576 76.611v163.283h97.717v-176.313c0-104.053-54.123-152.499-126.347-152.499z"/></svg></i></a></li></ul><div class="clearboth"></div></div>
		</div>

	
</div>
                <div class="mk-header-inner add-header-height">

                    <div class="mk-header-bg "></div>

                                            <div class="mk-toolbar-resposnive-icon"><svg  class="mk-svg-icon" data-name="mk-icon-chevron-down" data-cacheid="icon-5dde4defb6948" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1792 1792"><path d="M1683 808l-742 741q-19 19-45 19t-45-19l-742-741q-19-19-19-45.5t19-45.5l166-165q19-19 45-19t45 19l531 531 531-531q19-19 45-19t45 19l166 165q19 19 19 45.5t-19 45.5z"/></svg></div>
                    
                    
                            <div class="mk-header-nav-container one-row-style menu-hover-style-5" role="navigation" itemscope="itemscope" itemtype="https://schema.org/SiteNavigationElement" >
                                <nav class="mk-main-navigation js-main-nav"><ul id="menu-main-menu" class="main-navigation-ul"><li id="menu-item-5237" class="menu-item menu-item-type-post_type menu-item-object-page no-mega-menu"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/leadership/">Leadership</a></li>
<li id="menu-item-4991" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children no-mega-menu"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/pipeline/">Our Pipeline</a>
<ul style="" class="sub-menu ">
	<li id="menu-item-5419" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  rel="httpwpdbvbuildwebershandwickcompeanut-allergy-clinical-trials-studies" href="https://www.dbv-technologies.com/pipeline/viaskin-peanut/">Viaskin<sup>®</sup> Peanut</a></li>
	<li id="menu-item-8508" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/pipeline/viaskin-milk/">Viaskin<sup>®</sup> Milk</a></li>
	<li id="menu-item-5421" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/pipeline/viaskin-egg/">Viaskin<sup>®</sup> Egg</a></li>
</ul>
</li>
<li id="menu-item-5220" class="menu-item menu-item-type-post_type menu-item-object-page no-mega-menu"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/viaskin-platform/">Viaskin<sup>®</sup> Platform</a></li>
<li id="menu-item-5224" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor current-menu-ancestor current_page_ancestor menu-item-has-children no-mega-menu"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/">Investors &#038; Media</a>
<ul style="" class="sub-menu ">
	<li id="menu-item-9766" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/press-releases/">Press Releases</a></li>
	<li id="menu-item-5630" class="menu-item menu-item-type-custom menu-item-object-custom"><a class="menu-item-link js-smooth-scroll"  href="/events">Events &#038; Presentations</a></li>
	<li id="menu-item-5596" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor current-menu-ancestor current-menu-parent current-page-parent current_page_parent current_page_ancestor menu-item-has-children"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/">Financial Information</a><i class="menu-sub-level-arrow"><svg  class="mk-svg-icon" data-name="mk-icon-angle-right" data-cacheid="icon-5dde4defd01b5" style=" height:16px; width: 5.7142857142857px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 640 1792"><path d="M595 960q0 13-10 23l-466 466q-10 10-23 10t-23-10l-50-50q-10-10-10-23t10-23l393-393-393-393q-10-10-10-23t10-23l50-50q10-10 23-10t23 10l466 466q10 10 10 23z"/></svg></i>
	<ul style="" class="sub-menu ">
		<li id="menu-item-5604" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/sec-filings/">SEC Filings</a></li>
		<li id="menu-item-5605" class="menu-item menu-item-type-post_type menu-item-object-page current-menu-item page_item page-item-5038 current_page_item"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/amf-regulated-information/">AMF Regulated Information</a></li>
		<li id="menu-item-5606" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/annual-reports/">Annual Reports &#038; General Meetings</a></li>
	</ul>
</li>
	<li id="menu-item-5594" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/stock-information/">Stock Information</a></li>
	<li id="menu-item-5593" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/investor-faqs/">Investor FAQs</a></li>
	<li id="menu-item-8800" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/">Corporate Governance</a><i class="menu-sub-level-arrow"><svg  class="mk-svg-icon" data-name="mk-icon-angle-right" data-cacheid="icon-5dde4defd09cc" style=" height:16px; width: 5.7142857142857px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 640 1792"><path d="M595 960q0 13-10 23l-466 466q-10 10-23 10t-23-10l-50-50q-10-10-10-23t10-23l393-393-393-393q-10-10-10-23t10-23l50-50q10-10 23-10t23 10l466 466q10 10 10 23z"/></svg></i>
	<ul style="" class="sub-menu ">
		<li id="menu-item-8799" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/board-of-directors/">Board of Directors</a></li>
		<li id="menu-item-8798" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/audit-committee-2/">Audit Committee</a></li>
		<li id="menu-item-8797" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/compensation-committee/">Compensation Committee</a></li>
		<li id="menu-item-9074" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/nominating-committee/">Nominating Committee</a></li>
	</ul>
</li>
</ul>
</li>
<li id="menu-item-10451" class="menu-item menu-item-type-post_type menu-item-object-page no-mega-menu"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/careers/">Careers</a></li>
<li id="menu-item-5250" class="menu-item menu-item-type-post_type menu-item-object-page no-mega-menu"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/contact-us/">Contact Us</a></li>
</ul></nav>                            </div>
                            
<div class="mk-nav-responsive-link">
    <div class="mk-css-icon-menu">
        <div class="mk-css-icon-menu-line-1"></div>
        <div class="mk-css-icon-menu-line-2"></div>
        <div class="mk-css-icon-menu-line-3"></div>
    </div>
</div>        <div class=" header-logo fit-logo-img add-header-height  ">

	    <a href="https://www.dbv-technologies.com/" title="DBV Technologies">
	    
			             <img class="mk-desktop-logo dark-logo" title="The epicutaneous immunotherapy company" alt="The epicutaneous immunotherapy company" src="https://www.dbv-technologies.com/wp-content/uploads/2018/02/dbvtechnologies_logo_2018.png" />
			    
			    			    
			    			    
			    	    </a>
    </div>

                    
                    <div class="mk-header-right">
                                            </div>

                </div>
                
<div class="mk-responsive-wrap">

	<nav class="menu-main-menu-container"><ul id="menu-main-menu-1" class="mk-responsive-nav"><li id="responsive-menu-item-5237" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/leadership/">Leadership</a></li>
<li id="responsive-menu-item-4991" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/pipeline/">Our Pipeline</a><span class="mk-nav-arrow mk-nav-sub-closed"><svg  class="mk-svg-icon" data-name="mk-moon-arrow-down" data-cacheid="icon-5dde4defdb90b" style=" height:16px; width: 16px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M512 192l-96-96-160 160-160-160-96 96 256 255.999z"/></svg></span>
<ul class="sub-menu ">
	<li id="responsive-menu-item-5419" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  rel="httpwpdbvbuildwebershandwickcompeanut-allergy-clinical-trials-studies" href="https://www.dbv-technologies.com/pipeline/viaskin-peanut/">Viaskin<sup>®</sup> Peanut</a></li>
	<li id="responsive-menu-item-8508" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/pipeline/viaskin-milk/">Viaskin<sup>®</sup> Milk</a></li>
	<li id="responsive-menu-item-5421" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/pipeline/viaskin-egg/">Viaskin<sup>®</sup> Egg</a></li>
</ul>
</li>
<li id="responsive-menu-item-5220" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/viaskin-platform/">Viaskin<sup>®</sup> Platform</a></li>
<li id="responsive-menu-item-5224" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor current-menu-ancestor current_page_ancestor menu-item-has-children"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/">Investors &#038; Media</a><span class="mk-nav-arrow mk-nav-sub-closed"><svg  class="mk-svg-icon" data-name="mk-moon-arrow-down" data-cacheid="icon-5dde4defdc411" style=" height:16px; width: 16px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M512 192l-96-96-160 160-160-160-96 96 256 255.999z"/></svg></span>
<ul class="sub-menu ">
	<li id="responsive-menu-item-9766" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/press-releases/">Press Releases</a></li>
	<li id="responsive-menu-item-5630" class="menu-item menu-item-type-custom menu-item-object-custom"><a class="menu-item-link js-smooth-scroll"  href="/events">Events &#038; Presentations</a></li>
	<li id="responsive-menu-item-5596" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor current-menu-ancestor current-menu-parent current-page-parent current_page_parent current_page_ancestor menu-item-has-children"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/">Financial Information</a>
	<ul class="sub-menu ">
		<li id="responsive-menu-item-5604" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/sec-filings/">SEC Filings</a></li>
		<li id="responsive-menu-item-5605" class="menu-item menu-item-type-post_type menu-item-object-page current-menu-item page_item page-item-5038 current_page_item"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/amf-regulated-information/">AMF Regulated Information</a></li>
		<li id="responsive-menu-item-5606" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/annual-reports/">Annual Reports &#038; General Meetings</a></li>
	</ul>
</li>
	<li id="responsive-menu-item-5594" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/stock-information/">Stock Information</a></li>
	<li id="responsive-menu-item-5593" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/financial-information/investor-faqs/">Investor FAQs</a></li>
	<li id="responsive-menu-item-8800" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/">Corporate Governance</a>
	<ul class="sub-menu ">
		<li id="responsive-menu-item-8799" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/board-of-directors/">Board of Directors</a></li>
		<li id="responsive-menu-item-8798" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/audit-committee-2/">Audit Committee</a></li>
		<li id="responsive-menu-item-8797" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/compensation-committee/">Compensation Committee</a></li>
		<li id="responsive-menu-item-9074" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/investor-relations/corporate-governance/nominating-committee/">Nominating Committee</a></li>
	</ul>
</li>
</ul>
</li>
<li id="responsive-menu-item-10451" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/careers/">Careers</a></li>
<li id="responsive-menu-item-5250" class="menu-item menu-item-type-post_type menu-item-object-page"><a class="menu-item-link js-smooth-scroll"  href="https://www.dbv-technologies.com/contact-us/">Contact Us</a></li>
</ul></nav>
			<form class="responsive-searchform" method="get" action="https://www.dbv-technologies.com/">
		    <input type="text" class="text-input" value="" name="s" id="s" placeholder="Search.." />
		    <i><input value="" type="submit" /><svg  class="mk-svg-icon" data-name="mk-icon-search" data-cacheid="icon-5dde4defdd928" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1664 1792"><path d="M1152 832q0-185-131.5-316.5t-316.5-131.5-316.5 131.5-131.5 316.5 131.5 316.5 316.5 131.5 316.5-131.5 131.5-316.5zm512 832q0 52-38 90t-90 38q-54 0-90-38l-343-342q-179 124-399 124-143 0-273.5-55.5t-225-150-150-225-55.5-273.5 55.5-273.5 150-225 225-150 273.5-55.5 273.5 55.5 225 150 150 225 55.5 273.5q0 220-124 399l343 343q37 37 37 90z"/></svg></i>
		</form>
		

</div>
        
            </div>
        
        <div class="mk-header-padding-wrapper"></div>
                 
    </header>

				<div id="theme-page" class="master-holder  clearfix" itemscope="itemscope" itemtype="https://schema.org/Blog" >

						<div class="master-holder-bg-holder">
				<div id="theme-page-bg" class="master-holder-bg js-el"  ></div>
			</div>

			<div class="mk-main-wrapper-holder">

				<div id="mk-page-id-5038" class="theme-page-wrapper mk-main-wrapper mk-grid full-layout no-padding ">
					  <div class="theme-content no-padding" itemprop="mainEntityOfPage">
							

<div class="clearboth"></div>
	</div> 		</div> 			</div> 

				
<div class="mk-page-section-wrapper">
    <div id="page-section-2" class="mk-page-section self-hosted   full_layout full-width-2 js-el js-master-row    "    data-intro-effect="false">

        
            
            <div class="mk-page-section-inner">
                


<div class="mk-video-color-mask"></div>

                
                            </div>
            
            
        <div class="page-section-content vc_row-fluid mk-grid">
            <div class="mk-padding-wrapper">
<div style="" class="vc_col-sm-3 wpb_column column_container vc_custom_1516659497263 hidden-sm _ height-full">
	<div  class="vc_wp_custommenu wpb_content_element"><div class="widget widget_nav_menu"><div class="menu-ir-media-sub-menu-container"><ul id="menu-ir-media-sub-menu" class="menu"><li id="menu-item-8677" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor menu-item-8677"><a href="https://www.dbv-technologies.com/investor-relations/">Overview</a></li>
<li id="menu-item-8382" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8382"><a href="https://www.dbv-technologies.com/investor-relations/press-releases/">Press Releases</a></li>
<li id="menu-item-8390" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-8390"><a href="/events">Events &#038; Presentations</a></li>
<li id="menu-item-8383" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor current-menu-ancestor current-menu-parent current-page-parent current_page_parent current_page_ancestor menu-item-has-children menu-item-8383"><a href="https://www.dbv-technologies.com/investor-relations/financial-information/">Financial Information</a>
<ul class="sub-menu">
	<li id="menu-item-8384" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8384"><a href="https://www.dbv-technologies.com/investor-relations/financial-information/sec-filings/">SEC Filings</a></li>
	<li id="menu-item-8385" class="menu-item menu-item-type-post_type menu-item-object-page current-menu-item page_item page-item-5038 current_page_item menu-item-8385"><a href="https://www.dbv-technologies.com/investor-relations/financial-information/amf-regulated-information/">AMF Regulated Information</a></li>
	<li id="menu-item-8386" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8386"><a href="https://www.dbv-technologies.com/investor-relations/financial-information/annual-reports/">Annual Reports &#038; General Meetings</a></li>
</ul>
</li>
<li id="menu-item-8387" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8387"><a href="https://www.dbv-technologies.com/investor-relations/financial-information/stock-information/">Stock Information</a></li>
<li id="menu-item-8683" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8683"><a href="https://www.dbv-technologies.com/investor-relations/financial-information/investor-faqs/">Investor FAQs</a></li>
<li id="menu-item-8804" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-8804"><a href="https://www.dbv-technologies.com/investor-relations/corporate-governance/">Corporate Governance</a>
<ul class="sub-menu">
	<li id="menu-item-8803" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8803"><a href="https://www.dbv-technologies.com/investor-relations/corporate-governance/board-of-directors/">Board of Directors</a></li>
	<li id="menu-item-8802" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8802"><a href="https://www.dbv-technologies.com/investor-relations/corporate-governance/audit-committee-2/">Audit Committee</a></li>
	<li id="menu-item-8801" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8801"><a href="https://www.dbv-technologies.com/investor-relations/corporate-governance/compensation-committee/">Compensation Committee</a></li>
	<li id="menu-item-9075" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-9075"><a href="https://www.dbv-technologies.com/investor-relations/corporate-governance/nominating-committee/">Nominating Committee</a></li>
</ul>
</li>
</ul></div></div></div></div>

<div style="" class="vc_col-sm-9 wpb_column column_container vc_custom_1503427678329  _ height-full">
	
<h2 id="fancy-title-3" class="mk-fancy-title  simple-style   color-single">
	<span>
				
<h1>AMF Regulated Information</h1>
			</span>
</h2>
<div class="clearboth"></div>



<div class='dbv-docs-wrapper'><div class='dbv-docs-filters'><div><h4>Category:</h4><select class='dbv-filter-term'><option value=''>All</option></select></div><div><h4>Year:</h4><select class='dbv-filter-year'><option value=''>All</option></select></div></div><table class='dbv-docs'><thead><tr class='dbv-docs-head'><th>Document</th><th>Year</th><th>Terms</th></tr></thead><tbody><tr><td><p><span class='dbv-docs-date'>11/19/2019</span><span class='dbv-docs-terms'></span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/11/103119-va-1-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (88 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>11/05/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies to Present at the Stifel 2019 Healthcare Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/11/dbv-technologies-to-present-at-the-stifel-2019-healthcare-conference-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (130 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>10/24/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies to Highlight the Burden of Peanut Allergy and Patient Experiences with Viaskin Peanut at ACAAI 2019</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/10/dbv-technologies-to-highlight-the-burden-of-peanut-allergy-and-patient-experiences-with-viaskin-peanut-at-acaai-2019-3.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (182 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>10/16/2019 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/10/101519-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (88 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>10/15/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Closing of Global Offering</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/10/dbv-technologies-announces-closing-of-global-offering_101519.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (212 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/10/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (ADSs)</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/10/dbv-technologies-announces-full-exercise-of-underwriters-option_101019.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (219 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/09/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/10/dbv-technologies-announces-pricing-of-125-million-114-million-global-offering.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (190 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>10/08/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports September 30, 2019 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/10/dbv-press-release_100819.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (182 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/04/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut for the Treatment of Peanut Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/10/dbv-technologies-announces-fda-acceptance-of-bla-filing-for-viaskin-peanut-for-the-treatment-of-peanut-allergy-10.4.19.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (152 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>10/02/2019</span><span class='dbv-docs-terms'></span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/10/093019-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (87 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>09/19/2019 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/09/083119-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (88 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>08/07/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/08/dbv-technologies-submits-biologics-license-application-to-u.s.-food-and-drug-administration-for-viaskin-peanut-for-the-treatment-of-peanut-allergy-8.7.19.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (169 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>08/01/2019 | </span><span class='dbv-docs-terms'>Half-year financial reports | Press releases</span><p><h4>DBV Technologies Reports First Half 2019 Financial Results</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/08/1h-2019-pr_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (240 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/01/2019 | </span><span class='dbv-docs-terms'>Half-year financial reports</span><p><h4>Half-year financial report 2019</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/07/dbv_financial-report-1h2019_final_to-be-released.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (633 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports</td></tr><tr><td><p><span class='dbv-docs-date'>07/18/2019</span><span class='dbv-docs-terms'></span><p><h4>Amendment to the DBV Technologies Liquidity Contract with NATIXIS ODDO BHF and Half-Year Report</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/07/pr_half-year-liquidity-statement_071919.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (229 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>07/12/2019 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/07/063019-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (88 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>06/26/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Announces Appointment of Pharis Mohideen, M.D., as Chief Medical Officer</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/06/dbv-technologies-announces-appointment-of-pharis-mohideen-m.d.-as-chief-medical-officer-6.26.19.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (179 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>06/11/2019 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/06/053119-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (87 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>06/03/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/06/pr_june-ir-conferences_0603191-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (158 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>06/01/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies to Present Data from Epicutaneous Immunotherapy at EAACI 2019</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/06/dbv-technologies-to-present-data-from-epicutaneous-immunotherapy-at-eaaci-2019-6.1.19-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (162 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Announces Results of its 2019 Ordinary and Extraordinary General Meeting and the Appointment of Viviane Monges to the Board of Directors</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/dbv-technologies-announces-results-of-its-2019-ordinary-and-extraordinary-general-meeting-and-the-appointment-of-viviane-monges-to-the-board-of-directors-5.24.19.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (137 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>05/14/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Announces Departure of Deputy CEO David Schilansky</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/dbv-technologies-announces-departure-of-deputy-ceo-david-schilansky-5.14.19-copy.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (163 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Statutory Auditors’ supplementary report on the share capital increase with cancellation of preferential subscription rights<br />
Combined Shareholders’ Meeting of May 24, 2019<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/08-rapport-utilisation-de-la-dlgation-de-comptence-us.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (222 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Statutory Auditors’ report on the authorization to grant share subscription and/or share purchase options<br />
Combined Shareholders’ Meeting of May 24, 2019 – 28th resolution<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/07-rapport-so-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (171 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Statutory Auditors’ report on the authorization to grant free shares (existing and/or to be issued) to employees and/or certain corporate officers<br />
Combined Shareholders’ Meeting of May 24, 2019 – 27th resolution<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/06-rapport-autorisation-dagaen.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (191 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Statutory Auditors’ report on the issue of ordinary shares and/or marketable securities granting<br />
access to share capital reserved for members of a company savings plan<br />
Combined Shareholders’ Meeting of June May 24, 2019 – 26th resolution<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/05-rapport-sur-laugmentation-de-capital-rserve-aux-salaris-dlgation-de-comptence-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (195 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Statutory Auditors’ report on the issue of share subscription warrants (BSA), subscription and/or purchase warrants for new and/or existing shares (BSAANE) and redeemable subscription and/or purchase warrants for new and/or existing shares (BSAAR) with cancellation of preferential subscription rights to certain groups of persons<br />
Combined Shareholders’ Meeting of May 24, 2019 - 25th resolution<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/04-rapport-bsa-bsaane-bsaar-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (198 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Statutory Auditors’ report on the issue of ordinary shares granting access to ordinary shares or the allocation of debt securities, and/or marketable securities granting access to ordinary shares, to certain groups of persons meeting specific characteristics<br />
Combined Shareholders’ Meeting of May 24, 2019 – 22nd resolution<br />
<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/03-rapport-ak-personnes-qualifies-rso-22-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (256 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Statutory Auditors’ report on the issue of shares and/or other marketable securities with retention and/or cancellation of preferential subscription rights<br />
Combined Shareholders’ Meeting of May 24, 2019<br />
<br />
18th, 19th, 20th, 21st, 23rd and 24th resolutions<br />
<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/02-rapport-dlgation-globale-2018-dbv-technologies-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (301 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Statutory Auditors’ report on the cancelation of shares purchased by the Company<br />
Combined Shareholders’ Meeting of May 24, 2019 – 17th resolution<br />
<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/01-rapport-sur-rduction-de-capital-rso-17-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (208 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/06/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Notice of Meeting<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/notice-meeting-agm-2019.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (109 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/03/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Ordinary and Extraordinary General Meeting of May 24, 2019  Procedures for Obtaining Preparatory Documents for the General Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/pr-_agm_05_03_19.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (156 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/03/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, May 24, 2019</h4><p>Request to be sent documents and additional information<br />
<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/request-to-be-sent-documents-and-additional-information.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (121 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/03/2019</span><span class='dbv-docs-terms'></span><p><h4>Annual General Meeting, May 24, 2019</h4><p>List of candidates as directors<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/list-of-candidates-2019agm-va.pptx' target='_blank' class='dbv-docs-icon'>Download PDF (749 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>05/03/2019 | </span><span class='dbv-docs-terms'>General meeting | Outstanding shares and voting rights statements</span><p><h4>Annual General Meeting, May 24,2019</h4><p>Information regarding the total number of voting rights and total number of shares of the Company on April 19, 2019<br />
<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/voting-rights-041919-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (87 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting|Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>05/02/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/pr_may-ir-conferences_050219.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (219 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/30/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports March 31, 2019 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/dbv-technologies-reports-march-31-2019-cash-position.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (139 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/23/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting – May 24, 2019</h4><p>Proxy Card<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/proxy-card-2019.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>04/19/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting – May 24, 2019</h4><p>Preliminary notice of meeting<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/preliminary-notice-of-meeting-agm-may-24-2019.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (256 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>04/19/2019 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting – May 24, 2019</h4><p>Report of the Board of Directors to the Combined General Meeting of May 24, 2019<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/05/board-report-agm-may-24-2019-2.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (854 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>04/10/2019 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/040919-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (81 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>04/08/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Closing of Global Offering</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/dbv-technologies-announces-closing-of-global-offering_040819.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (184 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/08/2019 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/033119-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (87 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>04/05/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares (ADS)</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/dbv-technologies-announces-full-exercise-of-underwriters-option_040519.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (133 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/04/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Pricing of $70.4 million (€62.7 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/dbv-technologies-announces-pricing-of-70.4-million-62.7-million-global-offering_040419.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (162 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/03/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/dbv-technologies-announces-the-launch-of-a-proposed-global-offering_040319.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (172 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/01/2019 | </span><span class='dbv-docs-terms'>Annual Financial reports | Fees received by statutory auditors | Share buyback Programs</span><p><h4>20-F 2018</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/dbv-form-20-f-2018.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Fees received by statutory auditors|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>04/01/2019 | </span><span class='dbv-docs-terms'>Annual Financial reports</span><p><h4>DBV Technologies Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/04/dbv-technologies-announces-filing-of-2018-document-de-rfrence-and-2018-annual-report_040119.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (124 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports</td></tr><tr><td><p><span class='dbv-docs-date'>03/06/2019 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/03/022819-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (88 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>03/05/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Reports Full Year 2018 Financial Results and Provides Operational Update</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/03/dbv-technologies-reports-full-year-2018-financial-results-and-provides-operational-update-3.5.19.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (160 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>03/05/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Announces Appointment of Michel de Rosen as Non-Executive Chairman of the Board of Directors</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/03/dbv-technologies-announces-appointment-of-michel-de-rosen-as-non-executive-chairman-of-the-board_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (144 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>03/01/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/03/dbv-technologies-to-attend-upcoming-investor-conferences_030119.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (156 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>02/22/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/02/dbv-technologies-announces-publication-of-detailed-phase-iii-trial-results-evaluating-viaskin-peanut-2.22.19.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (187 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>02/08/2019 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/02/013119-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (87 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/04/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/02/dbv-technologies-to-present-data-on-epicutaneous-immunotherapy-at-aaaai-2019-2.4.19-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (190 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>02/01/2019 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present at the 8th Annual Leerink Partners Global Healthcare Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/01/dbv-technologies-to-present-at-the-8th-annual-leerink-partners-global-healthcare-conference_020119.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (124 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/17/2019 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/01/pr-oddo_half-year-liquidity-statement_01_17_19.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (148 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>01/11/2019 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/01/123118-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (87 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>01/03/2019</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Expands and Strengthens Leadership Team</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2019/01/dbv-technologies-expands-and-strengthens-leadership-team-1.3.19-final-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (644 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2019</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>12/19/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Provides Update on Viaskin Peanut for Children Four to 11 Years of Age</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/12/pr_bla_final_121918.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (170 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/17/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Daniel Tassé Severance package – Performance conditions – Board of Directors decisions dated on December 12th, 2018</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/12/dt-severance-extract-of-the-bod.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (499 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>12/12/2018</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/12/pr-isds-data-release_12.11.18-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (576 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>12/06/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/12/113018-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (88 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>11/20/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Presents Data at ACAAI 2018 on Investigational Viaskin Peanut for the Treatment of Peanut-Allergic Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/11/pr-acaai-data-release_11.20.18_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (415 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/16/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Appoints Daniel Tassé as Chief Executive Officer</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/11/pr_dt-ceo_11.16.18_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (451 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/07/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/11/103118-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (88 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>10/30/2018 | </span><span class='dbv-docs-terms'>Press releases | Quarterly financial information</span><p><h4>DBV Technologies Reports September 30, 2018 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/10/pr-dbv-3q-2018-cash-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (376 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>10/22/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/10/pr-bla-submission-102218-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (351 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/09/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/10/093018-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (256 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>09/07/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/09/083118-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (256 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>09/07/2018 | </span><span class='dbv-docs-terms'>Half-year financial reports</span><p><h4>DBV Technologies Reports First Half 2018 Financial Results</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/09/pr-dbv-1h18_financial-results_final_vdef.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (517 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports</td></tr><tr><td><p><span class='dbv-docs-date'>09/07/2018 | </span><span class='dbv-docs-terms'>Half-year financial reports</span><p><h4>Half Year Financial Report 2018</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/09/financial_report_h1_18.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (596 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports</td></tr><tr><td><p><span class='dbv-docs-date'>09/05/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies, Geneva University Hospitals and BioNet-Asia Presented Additional Phase I Data on the Use of an Investigational Epicutaneous Patch in Boosting Pertussis Vaccination at the European Congress of Immunology</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/09/pr-eci-pertussis_final_090518.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (430 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/27/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/08/073118-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (256 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>07/27/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports June 30, 2018 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/07/pr-dbv-q2-2018-cash-position.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (375 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/19/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/07/063018-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (256 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/13/2018 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>Half-Year Report on the DBV Technologies Liquidity Contract and Transfer to Oddo BHF</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/07/pr-natixis-liquidity_071318-002-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (373 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>06/26/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/062118-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (55 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>06/26/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Vote results<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/resultat-du-vote.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (63 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/26/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Quorum<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/quorum.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (73 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/11/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/053118-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (256 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>06/08/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Statutory Auditors’ report on the issue of shares and/or various marketable securities with retention and/or cancellation of preferential subscription rights<br />
<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/dlgation-globale-2017_dbv-technologies-vdfang.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (471 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/08/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Statutory Auditors&#039; report on the authorization to grant existing or future shares for no consideration<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/r30-rapport-aga-v3ang.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (635 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/08/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Statutory Auditors&#039; report on the authorization to grant share subscription and/or share purchase options<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/r31-rapport-so-v3ang.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (487 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/08/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Statutory Auditors&#039; report on the issue of ordinary shares and/or marketable securities granting access to share capital reserved for members of a company savings plan<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/r32-rapport-ak-adhrents-pee-v3ang.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (590 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/08/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Statutory Auditors’ report on the issue of ordinary shares granting access to ordinary shares or the allocation of debt securities, and/or marketable securities granting access to ordinary shares, with cancellation of preferential subscription rights for certain groups of persons meeting specific characteristics<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/rapport-attribution-ao_dbv-technologiesang.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (340 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/08/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Statutory Auditors’ report on the issue of share subscription warrants, subscription and/or purchase warrants for new and/or existing shares and/or redeemable subscription and/or purchase warrants for new and/or existing shares with cancellation of preferential subscription rights for certain groups of persons<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/rapport-bsa_dbv-technologiesang.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (335 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/06/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Notice of Meeting<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/avis-de-convocation_eng.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (106 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/01/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>List of candidates as Directors<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/06/list-of-candidates-2018-agm-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (296 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/01/2018 | </span><span class='dbv-docs-terms'>General meeting | Press releases</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Procedures for Obtaining Preparatory Documents for the General Meeting<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/pr-_agm_01_06_18_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (461 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/30/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Statutory Auditors&#039; report on the financial statements<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/statutory-report-financial.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (734 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/30/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Statutory Auditors&#039; report on the consolidated financial statements<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/report-on-consolidated-accounts.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (730 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/30/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Statutory Auditors&#039; special report on regulated agreements and commitments<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/report-regulated-agreemment-and-commitments.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (770 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/29/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Information regarding the total number of voting rights and total number of shares of the Company on May 18th, 2018<br />
<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/051818-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (256 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>05/29/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting, June 22, 2018</h4><p>Request to be sent documents and additional information<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/request-to-be-sent-documents-and-additional-information_va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (440 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/18/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting &#8211; June 22, 2018</h4><p>Report of the Board of Directors to the Combined General Meeting of June 22, 2018<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/board-report_fv.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (619 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/18/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting &#8211; June 22, 2018</h4><p>Preliminary notice of meeting<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/preliminary-notice-of-meeting.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (356 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/18/2018 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting &#8211; June 22, 2018</h4><p>Proxy Card<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/formulaire-de-vote.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/16/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Appointment of Michel de Rosen to its Board of Directors</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/pr-michel-de-rosen-bod_081618.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (346 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/14/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/043018-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (256 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/14/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Partners with FARE to Help Raise Awareness of Food Allergies in Support of the 21st Anniversary of Food Allergy Awareness Week</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/pr-dbv_fare-faaw-2018_051418_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (356 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/08/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present New Clinical Data from Viaskin Platform at the 2018 EAACI Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/05/eaaci-curtain-raiser_050818-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (460 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/01/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/04/may-ir-pr-final_050118.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (306 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/05/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and  total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/04/033118-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (156 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/26/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Closing of Underwriters’ Option to Purchase Additional Shares in Global Offering</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/equity-option-closing-pr_032618_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (321 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/23/2018</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/pr-equity-closing-eng_032318.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (324 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>03/21/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Pricing of $150.0 million (€122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/pricing-equity-pr-final-032118.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (458 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/20/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/offering-pr-final_032018.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (479 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/16/2018 | </span><span class='dbv-docs-terms'>Annual Financial reports | Fees received by statutory auditors | Share buyback Programs</span><p><h4>DBV Form 20-F 2017</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/dbv-form-20-f-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Fees received by statutory auditors|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>03/16/2018 | </span><span class='dbv-docs-terms'>Annual Financial reports | Fees received by statutory auditors | Share buyback Programs</span><p><h4>Document de Référence 2017</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/dbv_ddr_2017_complet_visaamf-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (5 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Fees received by statutory auditors|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>03/16/2018 | </span><span class='dbv-docs-terms'>Annual Financial reports | Press releases</span><p><h4>DBV Technologies Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/pr-ddr-form-20f-2017pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (319 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/14/2018</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies Reports Full Year 2017 Financial Results</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/pr-dbv-fy17-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (398 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>03/07/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present at the Barclays Global Healthcare Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/pr-barc-eng-final-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (314 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/28/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/022818-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (156 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/26/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/02/4511-pr-miles-final_eng-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/20/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports December 31, 2017 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/02/4496-pr-dbv-q4-2017-cash-position.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (924 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/14/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/02/4477-dbv_pr-vp-reg.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,017 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/13/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/02/4458-013118-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (158 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/12/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Highlight Viaskin Technology Platform at the 2018 AAAAI/WAO Joint Congress</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/02/4444-aaaai-curtain-raiser-pr-feb-12-eng-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/01/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/02/4388-pr-feb-ir-2018-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (643 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/16/2018 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>Half-Year Report on the DBV Technologies Liquidity Contract with Natixis</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/4375-pr-half-year-liquidity-contract-nat.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (643 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>01/12/2018 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/4369-123117-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (159 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/03/2018 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present at the 36th Annual J.P. Morgan Healthcare Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/4352-pr-jpm-2018-pdf-version.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (642 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2018</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/22/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4348-121517-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (159 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/05/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4339-1117-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (159 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/04/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies CEO, Chairman, and Co-Founder, Dr. Pierre-Henri Benhamou Recognized for His Lasting Impact on the Food Allergy Community and Research Advancement by FARE (Food Allergy Research &#038; Education)</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4330-pr-fare-dbv-12-04-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,021 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/28/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Citi’s 2017 Global Healthcare Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4320-pr-dbv-dec-2017-ir-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (642 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/20/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4305-pr_realise-11-20-2017-eng-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/19/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/pr-realise-11-19-2017-eng-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/14/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Publication of Positive Data from Phase IIb Trial and Long-Term Study of Viaskin Peanut inthe Journal of the American Medical Association</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4291-pr-jama-final-111417.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/13/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4287-1017-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (159 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/31/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports September 30, 2017 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4277-pr-dbv-q3-2017-cash-position-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (923 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/20/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4257-pr-pepites-topline-results-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/20/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut- Allergic Patients Four to 11 Years of Age</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/pr-pepites-topline-results-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/17/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4253-0917-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (158 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/12/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/03/pr-realise-10-12-17-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,018 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/12/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/4244-pr-realise-10-12-17b-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,018 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>09/05/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4239-0817-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (158 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>09/01/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4230-pr_dbv_sept_2017_ir.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (709 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/29/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4221-pr-people-eng-pdf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (323 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/22/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4217-0717-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (40 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/02/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4190-pr_epitope_fpi.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,023 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/28/2017 | </span><span class='dbv-docs-terms'>Half-year financial reports</span><p><h4>Half Year Financial Report 2017</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4181-financial-report-half-year-2017.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (687 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports</td></tr><tr><td><p><span class='dbv-docs-date'>07/28/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports First Half 2017 Financial Results</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4179-pr_1h17_results.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,015 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/07/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4175-0617-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (57 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/05/2017 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>Half-Year Report on the DBV Technologies Liquidity Contract with Natixis</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4167-pr-half-year-liquidity-contract-nat.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (111 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>06/20/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Quorum<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4163-ag_150617_quorum.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (27 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/20/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Poll Results<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4165-ag_150617_resultats_scrutin.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (150 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/17/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4148-dbv-eaaci_061717_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/15/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Results of its 2017 Ordinary and Extraordinary General Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4137-pr_agm_resolutions_061517.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (926 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/15/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Appointment of Julie O’Neill to Board of Directors</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4135-pr_agm_bod_061517.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,019 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/12/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4131-0517-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (57 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/01/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4113-pr_dbv_june_2017_ir.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (925 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/31/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Notice of Meeting <br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4117-avis-de-convocation_eng.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (175 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Statutory Auditors&#039; report on the authorization to grant share subscription and/or share purchase option (Resolution 14)<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4078-dbv-technologies-rapport-autorisati.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (284 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting | Press releases</span><p><h4>Ordinary and Extraordinary General Meeting of June 15, 2017 Procedures for Obtaining Preparatory Documents for the General Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4072-agm-2017-documents.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Statutory auditors’ supplementary report on the issue of share subscription warrants with cancellation of preferential subscription rights<br />
Chairman and Chief Executive Officer decision of June 21, 2016, pursuant to the sub-delegation of the Board of Directors’ meeting of June 21, 2016<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4088-rapport-complementaire-emission-bsa.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (289 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Statutory auditors’ supplementary report on the issue of share subscription warrants with cancellation of preferential subscription rights<br />
Chairman and Chief Executive Officer decision of December 9, 2016, pursuant to the subdelegation of the Board of Directors’ meeting of December 9, 2016 <br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4090-rapport-complementaire-emission-bsa.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (288 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Statutory Auditors’ report on the consolidated financial statements<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4086-30550-fr-t02-rapport-comptes-consol.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (208 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Statutory auditors’ report prepared in accordance with Article L. 225-235 of the French Commercial Code (Code de Commerce) on the report prepared by the Chairman of the Board of Directors<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4084-30500-fr-t04-1-rci-dbv-evaluatif-20.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (200 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Statutory auditors’ report on the issue of share subscription warrants, subscription and/or purchase warrants for new and/or existing shares and/or redeemable subscription and/or purchase warrants for new and/or existing shares with cancellation of preferential subscription rights for certain categories of persons (Resolution 16)<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4080-dbv-technologies-rapport-bsa-bsaane.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (228 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Report of one of the statutory auditors, designated as an independent third-party entity, on the review of consolidated social, environmental, and societal information presented in the management report<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4082-dbv-rse-fy2016-rapport-oti-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (342 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Statutory auditors’ report on the issue of ordinary shares and/or marketable securities granting access to share capital reserved for members of a company savings plan (resolution 17)<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4076-dbv-technologies-rapport-adherents-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (193 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/24/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>List of Candidates as Directors<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4068-fiche-candidature_va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (357 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/23/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Proxy Card<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4054-dbv-technologies-formulaire-de-vote.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/23/2017 | </span><span class='dbv-docs-terms'>General meeting | Outstanding shares and voting rights statements</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Monthly information regarding the total number of voting rights and total number of shares of the Company on May 10th 2017<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4048-100517-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (158 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting|Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>05/12/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4039-0417-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (158 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/10/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Board of Director&#039;s report on the combined shareholder&#039;s meeting of June 15th, 2017<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4036-report-on-resolutions-final-version.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (420 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/10/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Preliminary Notice of Meeting<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4037-avis-prealable-ag-2017-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (286 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/10/2017 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Annual General Meeting June 15th, 2017</h4><p>Approval of the principles and criteria for determination, allocation and assignment of the components making up the total compensation and benefits due to executive corporate offices (Chairman and CEO and Executive Vice Presidents) <br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4034-cadre-rapport-say-on-pay-ex-ante-sa.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (419 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/08/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Highlights Research Presentation of EPIT® for the Treatment of Crohn&#8217;s Disease at Digestive Disease Week 2017</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4025-pr-ddw-2017-050817_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,020 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/02/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/4008-pr-dbv-may-2017-ir-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (928 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/28/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports March 31, 2017 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3993-pr-dbv-q1-2017-cash-position.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (927 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/05/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend the 10th Kempen Life Sciences Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3980-pr_dbv_kempen_conference_april_2017.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (643 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/05/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3989-0317-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (159 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/30/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies, BioNet-Asia and Geneva University Hospitals Announce Phase I Trial Results of Viaskin rPT in Pertussis Booster Vaccination</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3971-pr-viaskin-rpt-033017-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (355 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/22/2017 | </span><span class='dbv-docs-terms'>Annual Financial reports | Internal control and corporate governance reports | Press releases | Share buyback Programs</span><p><h4>20F- Form 2016</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3964-dbv-20-f-bannerless.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Internal control and corporate governance reports|Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>03/22/2017 | </span><span class='dbv-docs-terms'>Annual Financial reports | Internal control and corporate governance reports | Press releases | Share buyback Programs</span><p><h4>DBV Technologies Announces Filing of its 2016 “Document de Référence” and Annual Report on Form 20-F</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3955-pr-ddr-form-20f-2016_vfinal.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,008 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Internal control and corporate governance reports|Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>03/15/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports Full Year 2016 Financial Results</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3942-pr-dbv-4q16-full-year-result-vdef.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (194 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/10/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3935-pr-realise-eor-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/07/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3929-0217-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (158 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>03/05/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut Allergic Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3920-dbv-aaaai-data-release-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/01/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3911-pr-march-2017-ir-events-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (927 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/20/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports December 31, 2016 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3902-pr-dbv-4q16-cash-position-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (927 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/10/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT®</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3878-dbv-aaaai-curtain-raiser_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/05/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements | Press releases</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3874-0117-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (155 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/03/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Completion of Enrollment of Phase IIA Study of Viaskin Milk for the Treatment of Pediatric Eosinophilic Esophagitis</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3829-pr-dbv-smilee-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,020 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/26/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present at the LEERINK Partners 6th Annual Global Healthcare Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3813-pr-dbv-leerink-conference-2017-fina.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (927 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/09/2017 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Financial Calendar 2017</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3804-pr-dbv-financial-newsflow.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (121 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/04/2017 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>DBV Technologies Presents its Half-year Statement of the Liquidity Contract</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3742-regulatory-press-release-bilan-seme.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (940 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>01/04/2017 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/3736-1216-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (155 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2017</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>12/07/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3727-1116-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (155 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>11/17/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies, BioNet-Asia and Geneva University Hospitals Complete Dosing in First Cohort of Phase I Study of Viaskin rPT for Booster Vaccination Against Pertussis</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3713-pr-dsmb-pertussis-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (347 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/16/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3708-1016-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (155 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>11/12/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Poster Presentations at the 2016 American College of Allergy, Asthma, and Immunology Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2016/11/3700-pr-dbv-acaai-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/10/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3690-pr-dbv-investor-conferences-2016-fi.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (931 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/08/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3683-dbv-pr-miles-eor-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (150 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/03/2016 | </span><span class='dbv-docs-terms'>Press releases | Quarterly financial information</span><p><h4>DBV Technologies Reports September 30, 2016 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3674-pr-dbv-3q16-results-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (928 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>10/26/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3665-pr-cofar6-jaci-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/24/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3654-pr-olfus-year-3-data-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/17/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3643-0916-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (155 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>09/21/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3628-pr-dbv-viaskin-milk-fast-track-fina.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>09/06/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies, BioNet-Asia and the Geneva University Hospitals Initiate Phase I Study of Viaskin rPT for Pertussis Booster Vaccination</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3583-pr-pertussis-trial-initiation-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (362 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>09/01/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3574-pr-sept-ir-2016-conferences-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (941 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/03/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3570-0716-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>08/01/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Expansion of Clinical Program of Viaskin Peanut for the Treatment of Peanut Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3566-pr-dbv-realise-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/28/2016 | </span><span class='dbv-docs-terms'>Half-year financial reports | Press releases</span><p><h4>First Half of 2016 Condensed Consolidated Financial Statements</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3552-dbv_financial-report-half-year-2016.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/28/2016 | </span><span class='dbv-docs-terms'>Half-year financial reports | Press releases</span><p><h4>DBV Technologies Reports Interim Financial Results for the First Half of 2016</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3543-pr-h1-topline-h1-2016-vdef.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (205 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/11/2016 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>Half year update on the DBV Technologies liquidity agreement</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3537-pr-half-year-statement.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (923 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>07/08/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3533-0616-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>07/05/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Proudly Welcomes Dr. Lucia Septién as Chief Medical Officer</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3452-pr-dbv-dr-lucia-septien-cmo-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,023 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/27/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3443-pr-pepites-recruitment-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,022 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/23/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Quorum<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3439-quorum.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (34 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/23/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Voting results<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3437-resultat-des-votes.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (329 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/21/2016 | </span><span class='dbv-docs-terms'>General meeting | Press releases</span><p><h4>DBV Announced Results of its 2016 Annual Meeting of Shareholders</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3419-pr-ag-2016-resolutions.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (927 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/21/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Expands its Board of Directors with the Appointments of Claire Giraut and Maïlys Ferrere</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3415-pr-bod-directors-june-21-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/16/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present at the JMP Securities Life Sciences Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3400-pr-june-ir-2016-conference-jmp-fina.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (640 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/15/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Late-Breaking Presentation at EAACI Highlights Viaskin® Peanut Data Providing Biomarker Insights for Monitoring Treatment Progression</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3391-pr-eaaci-late-breaker-release-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,023 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/13/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Publication of Preclinical Data in JACI Suggesting EPIT® Provides Sustained Protection Against Anaphylaxis</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3382-pr-jaci-publication-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/07/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Appointment of Leading Japanese Allergist, Dr. Motohiro Ebisawa, to its Scientific Advisory Board</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3369-pr-dbv-ebisawa-sab-member-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,023 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/06/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Notice of Meeting<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3363-dbv-technologies_balo_eng.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (200 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/06/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3365-0516-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>06/06/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>List of candidates as Directors<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3373-fiche-candidature-va-vel.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/01/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Data at EAACI 2016 Highlight Its Expansive Product Development in Food Allergies</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3350-pr-eaaci-2016-curtain-raiser-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/31/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies and Nestlé Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test for Pediatric Milk Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3336-pr-mag1c-final-05312016.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/30/2016 | </span><span class='dbv-docs-terms'>General meeting | Press releases</span><p><h4>Mixed General Assembly of June 21, 2016 Procedures for obtaining preparatory documents for the Assembly</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3322-pr-mixed-general-assembly-june-21-2.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (943 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/27/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>STATUTORY AUDITORS’ SUPPLEMENTARY REPORT ON THE ISSUE OF SHARE SUBSCRIPTION WARRANTS WITH CANCELLATION OF PREFERENTIAL SUBSCRIPTION RIGHTS<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3334-rapport-complementaire-emission-bsa.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (285 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/27/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>STATUTORY AUDITORS’ SUPPLEMENTARY REPORT ON THE ISSUE OF SHARE SUBSCRIPTION WARRANTS WITH CANCELLATION OF PREFERENTIAL SUBSCRIPTION RIGHTS<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3332-rapport-complementaire-emission-bsa.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (286 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/27/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Statutory Auditors&#039;report on resolutions n°24<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3314-dbv-rapport-augmentation-de-capital-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (283 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/27/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Statutory Auditors&#039;report on resolutions n°18, 19, 20 and 21<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3310-dbv-rapport-emission-actions-ordina.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (330 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/27/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Statutory Auditors&#039;report on resolutions n°25<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3316-dbv-rapport-sur-emission-bsa-bsaane-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (284 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/27/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Statutory Auditors&#039;report on resolutions n°17 and 21<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3308-dbv-rapport-emission-actions-ordina-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (283 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/27/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Statutory Auditors&#039;report on resolutions n°22<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3312-dbv-rapport-sur-emission-actions-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (281 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/27/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Monthly information regarding the total number of voting rights and total number of shares of the Company on May 16th, 2016<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3306-0516_droit_de_vote_160516_va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (78 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/20/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3271-pr-may-june-ir-2016-conferences-fin.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (941 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/16/2016 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>June 21, 2016 General Assembly</h4><p>Notice prior to Meeting <br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3251-dbv-technologies_draft_balo_eng-vf-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (335 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/05/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3247-0416-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>04/29/2016 | </span><span class='dbv-docs-terms'>Press releases | Quarterly financial information</span><p><h4>DBV Technologies Reports March 31, 2016 Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3225-pr-cash-position-march-2016-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (930 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>04/28/2016 | </span><span class='dbv-docs-terms'>Annual Financial reports | Prospectus</span><p><h4>20-F Form 2015</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3237-168186acl.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Prospectus</td></tr><tr><td><p><span class='dbv-docs-date'>04/28/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Filing of 2015 “Document de Référence” and 2015 Annual Report on Form 20-F</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3234-pr-ddr-form-20f-2015-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,010 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/27/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3216-pr-may-ir-2016-conferences-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (941 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/11/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Publication of Experimental Data on Targeted Regulatory T Cell Induction during Epicutaneous Immunotherapy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3195-pr-cellular-molecular-immunology-fi.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/07/2016 | </span><span class='dbv-docs-terms'>Annual Financial reports | Press releases</span><p><h4>DBV Technologies Reports Full Year 2015 Financial Results</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3184-pr-dbv-2015-fy-results-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/05/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3205-0316-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>03/08/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/3072-0216-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>03/06/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Additional Phase IIb Trial Results with Viaskin Peanut Presented at the 2016 AAAAI Meeting Continue to Support Treatment Safety, Efficacy and Compliance</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3063-olfus-vipes-press-release-final-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/04/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Presentation from NIAID-sponsored CoFAR6 Phase II Trial Reaffirming Viaskin® Peanut Safety and Efficacy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3061-pr-aaaai-cofar6-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/01/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences and Events</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3055-pr-march-ir-2016-conference-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (937 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/25/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Publication of Phase Ib Trial Results in the Journal of Allergy and Clinical Immunology (JACI) Supporting Safety and Tolerability of Viaskin® Peanut</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3033-pr-jaci-phase-1b-publication-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/15/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports December 31, 2015, Cash Position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/3009-pr-cash-position-december-2015-fina.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (925 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/10/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present New Data at the 2016 AAAAI Annual Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2993-pr-aaaai2016-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/08/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present at the LEERINK Partners 5th Annual Global Healthcare Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2849-pr-leerink-conference-feb-2016-fina.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (642 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/05/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2832-0116-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>01/26/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Proudly Welcomes Edward Jordan as Senior Vice President Commercial Operations North America</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2807-pr-edward-jordan-appointment-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,013 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/08/2016 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2794-1215-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>01/08/2016 | </span><span class='dbv-docs-terms'>Share buyback Programs</span><p><h4>DBV Technologies Presents its Half-year Statement of the Liquidity Contract</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2724-regulatory-press-release-bilan-seme.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (647 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>01/08/2016 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces 2016 Financial Calendar</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2728-pr_dbv_financial-newsflow.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (939 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/07/2016 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>DBV Technologies Presents its Half-year Statement of the Liquidity Contract</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2724-regulatory-press-release-bilan-seme-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (647 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2016</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>12/10/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>First Experimental Results for the Treatment of Colitis with Viaskin® will be presented at the Crohn&#8217;s &#038; Colitis Foundation of America&#8217;s 2015 Advances in IBD Conference (AIBD)</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2698-pr-ibd-crohn.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/07/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Initiation of Phase III Study of Viaskin® Peanut for the Treatment of Peanut Allergic Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2685-pr_dbv_first_patient_pepites.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/18/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present Preclinical Data on its Viaskin® Technology for RSV Vaccination at the 2015 RSV Vaccines for the World Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2648-pr-rsvvw-abstract.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/12/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Enrollment of First Patient in Phase IIA Study in Pediatric Eosinophilic Esophagitis</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2639-pr-viaskin-milk-eoe-phase-iia-1st-p.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (560 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/05/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company-November</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2694-1115-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>11/05/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company-October</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2359-1015-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>11/03/2015 | </span><span class='dbv-docs-terms'>Press releases | Quarterly financial information</span><p><h4>DBV Technologies Reports Interim Financial Results for the third quarter of 2015</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2350-pr-q3-topline-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (515 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>10/22/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces the Appointment of Michael J. Goller to its Board of Directors</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2341-pr-dbv-board-modification-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/14/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces First Patient Enrolled in Phase II Study of Viaskin Milk</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2334-pr-dbv-viaskin-milk-part-b-launch.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (511 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/05/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Follow-Up Study of Viaskin® Peanut Shows Significant Increase in Peanut Consumption and Treatment Benefit in Peanut Allergic Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2325-pr-dbv-olfus-results.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (821 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/02/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2319-0915-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (79 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>09/11/2015</span><span class='dbv-docs-terms'></span><p><h4>DBV Technologies To Enter SBF 120 Index</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2308pr-dbv-sbf-120-index.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (367 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'></td></tr><tr><td><p><span class='dbv-docs-date'>09/08/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Invited to Present at the Royal Society of Medicine 11th Medical Innovations Summit</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2304pr-dbv-royal-society.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (356 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>09/03/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences and Events</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2300pr-dbv-septembre-conferences.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (509 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/31/2015 | </span><span class='dbv-docs-terms'>General meeting | Press releases</span><p><h4>Extraordinary General Assembly &#8211; 9/21/15</h4><p>DBV Technologies’ Extraordinary General Assembly on September 21, 2015<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2291communique-mise-a-disposition-des-d.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (942 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/27/2015 | </span><span class='dbv-docs-terms'>General meeting | Outstanding shares and voting rights statements</span><p><h4>Extraordinary General Assembly &#8211; 9/21/15</h4><p>Monthly information regarding the total number of voting rights and total number of shares of the Company on August 17th, 2015<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2285150817-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting|Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>08/27/2015 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Extraordinary General Assembly &#8211; 9/21/15</h4><p>Request to be sent documents and additional information<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2281demande-d-envoi-de-documents-et-ren.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (273 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>08/27/2015 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Extraordinary General Assembly &#8211; 9/21/15</h4><p>Proxy Card<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2279formulaire-de-vote-version-finale.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>08/17/2015 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Extraordinary General Assembly &#8211; 9/21/15</h4><p>Report by the Board of Directors - Notice of extraordinary General Meeting on September 21, 2015<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2268rapport-ca-ag-sept-2015-final_en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (95 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>08/17/2015 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Extraordinary General Assembly &#8211; 9/21/15</h4><p>Notice of meeting<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2266150817-avis-prealable-balo_en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (36 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>08/04/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/22530715-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>07/27/2015 | </span><span class='dbv-docs-terms'>Half-year financial reports | Press releases</span><p><h4>DBV Technologies Reports Interim Financial Results for the First Half of 2015</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2242pr-h1-topline.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (659 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/27/2015 | </span><span class='dbv-docs-terms'>Half-year financial reports</span><p><h4>First Half of 2015 Consolidated Financial Statements</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2244ifr-june-2015-vdef.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports</td></tr><tr><td><p><span class='dbv-docs-date'>07/20/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Closing of $281.5 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2221pr-closing-of-follow-on-public-offe.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (499 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/15/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Pricing of Underwritten Public Offering of Ordinary Shares</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2197pr-dbv-pricing-of-follow-on-public-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (501 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/14/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Launch of Proposed Underwritten Public Offering of Ordinary Shares</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2184pr-dbv-launch-of-proposed-follow-on.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (501 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/08/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>IND Acceptance from FDA for a proof-ofconcept trial using Viaskin® Milk in MilkInduced Eosinophilic Esophagitis in Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2155pr-viaskin-milk-eoe-ind.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (638 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/02/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies announces the filing of a registration statement on Form F-1 in view of an offering of new shares in the form of American Depositary Shares, as well as the filing of its Reference Document</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2144pr-f-1-ddr-filing.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (649 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/02/2015 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>Half year update on the DBV Technologies liquidity agreement</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2133pr-liquidity-contract.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (199 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>07/02/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/21310615-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>06/30/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Completion of Part A of the MILES Study Evaluating the Safety of Viaskin® Milk in Pediatric Cow’s Milk Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2120pr-viaskin-milk-part-a-dsmb-doses.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (641 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/26/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Proudly Welcomes Dr. Hugh Sampson as Chief Scientific Officer</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2111pr-hugh-sampson-appoitment.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (516 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/23/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies’ June 23, 2015 Combined Shareholders’ Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2090pr-ag2015.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (504 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/23/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Confirms Planned Initiation of Viaskin® Peanut Global Phase III Clinical Trial in Children Following Endof-Phase II Meeting with FDA and PIP approval by EMA</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2088pr-regulatory-clinical-pathway-vias.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (799 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/10/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Key Scientific Data Demonstrating that Epicutaneous Administration May Reactivate Protective Immunity against Pertussis in an experimental model published in Vaccine</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2051pr-vaccine-boost-preclinical-data.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (158 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/09/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/20840515-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>06/08/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Presents Clinical and Scientific Data at the EAACI Congress</h4><p>Data presented on VIPES continues to show strong treatment effect and clear dose response. New Preclinical research data characterizes additional mechanistic features of Epicutaneous Immunotherapy (EPIT®).<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/2044pr-eaaci-full-presentation-symposiu.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (660 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/04/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces EMA Paediatric Committee (PDCO) positive opinion on the Paediatric Investigation Plan for Viaskin® Peanut for the Treatment of Peanut Allergic Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/2020pr-viaskin-peanut-pip.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (665 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/02/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1980pr-dbv-june-2015-conferences.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (651 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/01/2015 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Report of the Board of Directors concerning the intended merger transactions</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1984dbv-technologies-rapport-du-ca-gb.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (269 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>06/01/2015 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>List of candidates as Director</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1976liste-administrateurs-2015-va-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (196 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/29/2015 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1974150518-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/20/2015 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>ORDINARY AND EXTRAORDINARY GENERAL ASSEMBLY OF THE SHAREHOLDERS DATED JUNE 23, 2015</h4><p>Agenda<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1934resolutions-va-finales-150520.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (364 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/20/2015 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Publication of the Resolutions Proposed to the Mixed General Assembly of DBV</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1936pr-publication-of-the-resolutions-a.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1,008 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/05/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present at Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1919pr-dbv-may-2015-conferences.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (368 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/04/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/19300415-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>04/30/2015 | </span><span class='dbv-docs-terms'>Annual Financial reports</span><p><h4>20-F Form</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/191720f-vf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports</td></tr><tr><td><p><span class='dbv-docs-date'>04/29/2015 | </span><span class='dbv-docs-terms'>Press releases | Quarterly financial information</span><p><h4>Topline Financial Results for First Three Months of 2015</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1903pr-q1-topline-vdef-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (228 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>04/28/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Selected to Enter Euronext’s Tech 40 Label</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1896pr-dbv-label-tech-40.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (354 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/15/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present Viaskin® Data at the 2015 EAACI Congress</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1887pr-eaaci-abstracts-symposium.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (800 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/09/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Receives FDA Breakthrough Therapy Designation for Viaskin Peanut for the Treatment of Peanut Allergy in Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1875pr-viaskin-peanut-breakthrough-desi.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (668 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/01/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/18730315-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>03/25/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports Full Year 2014 Financial Results</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1860pr-dbv-2014-fy-results-vdef.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (263 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/10/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Appoints Daniel Soland to Board of Directors</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1848pr-dan-soland-board-appoitment-fina.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (514 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/10/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/18560215-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>03/06/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present at Upcoming Investor Conferences</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1842dbv-march.april-conferences-v1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (637 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/24/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Viaskin® Data Presented at AAAAI Meeting Show Safety and Efficacy in the Treatment of Food Allergies</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1831aaaai-congress-2015-vfinal.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (820 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/13/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Welcomes Dr. J-P Moreau to its Scientific Advisory Board</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1771pr-sab-jp-moreau-vf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (92 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/11/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/17670115-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>02/03/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Present at the 2015 Leerink Partners Global Healthcare Conference in New-York (USA)</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1754pr-dbv-leerink-conference-vf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (75 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/03/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Largest Presence Ever of DBV Technologies at 2015 Allergy Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1758pr-dbv-aaaai-abstract-vf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (103 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/29/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Topline Financial Results   for Full Year 2014  </h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1745pr-2014-fy-topline-vclean.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (170 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/14/2015 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>Half year update on the DBV Technologies liquidity agreement</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1736pr-half-year-liquidity-contract-dec.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (128 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>01/12/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Publication in the Journal of Allergy and Clinical Immunology of Data Demonstrating that Epicutaneous Immunotherapy may Influence the Natural History of Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1723pr-jaci-publication-epit-new-sensit.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (120 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/08/2015 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Provides Organizational Update</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1716pr-dbv-2014-data-new-organisation-v.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (111 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/06/2015 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/17121214-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2015</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>12/09/2014 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/16991114-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>11/20/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Initiates Phase I/II Clinical Trial with Viaskin Milk for the Treatment of Children with Cow’s Milk Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1688pr-dbv-first-patient-in-miles-vf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (105 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/03/2014 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/16801014-va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>10/23/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Global offering of DBV Technologies ordinary shares</h4><p>Over-allotment option exercised in full<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1676pr-dbv_greenshoe_en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (110 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/22/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies S.A. Announces Pricing of Global Offering</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1621pr-dbv-technologies-re-ipo-pricing-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (111 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/20/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies S.A. Announces Proposed Global Offering</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1617dbv-technologies_launch-press-relea.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (145 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/14/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Topline Financial Results for First Nine Months 2014</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1607141014_pr_dbv_q3_topline_financial_.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (83 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/01/2014 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1603dbv_09302014_monthly_information_to.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>09/22/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Primary Endpoint Met in VIPES, Viaskin Peanut’s Phase IIb Clinical Trial in Peanut Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1522pr-vipes-results-vf.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (149 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/26/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Attend the Goldman Sachs European Biotech Symposium</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1240pr_dbv_to-attend-goldman-sachs-euro.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (69 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/12/2014 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/14522014_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (80 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>07/28/2014 | </span><span class='dbv-docs-terms'>Half-year financial reports | Prospectus</span><p><h4>2014 Half-year Financial report</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1182dbv_2014-half-year-report.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports|Prospectus</td></tr><tr><td><p><span class='dbv-docs-date'>07/28/2014 | </span><span class='dbv-docs-terms'>Half-year financial reports | Press releases</span><p><h4>DBV Technologies Reports Financial Results for the First Six Months of 2014</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/984pr_dbv_reports-financial-results-for.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (187 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/17/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Consortium of Food Allergy Research Completes Recruitment of NIH-sponsored CoFar6 Phase II Trial with DBV’s Viaskin® Peanut in Treatment of Peanut Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1236pr_dbv_consortium-of-food-allergy-r.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (108 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/17/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Completes last &#8220;food challenge&#8221; visit of last Peanut-Allergic patient in VIPES Phase IIb Clinical Study</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1404pr_dbv_completes-last-food-challeng.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (116 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/04/2014 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/12522014_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Clinical Trial Agreement to Develop a Treatment for Milk-Induced Eosinophilic Esophagitis in Children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1270611452.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (112 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/13/2014 | </span><span class='dbv-docs-terms'>Annual Financial reports | Prospectus</span><p><h4>2013 Reference Document</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1064dbv_2013_document-de-reference.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (3 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Prospectus</td></tr><tr><td><p><span class='dbv-docs-date'>05/12/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies to Host and Webcast Investor Day in New York City on May 21, 2014</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1306611437.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (107 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/06/2014 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/14620414-20va.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (16 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>04/17/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies publishes its 2013 Registration Document and its 2013 Annual Financial Report</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1432pr_dbv_publishes-2013-registration-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (137 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/16/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Announces the First reported case of a long term sustained effect of Peanut desensitization after Epicutaneous Immunotherapy (EPITTM) with Viaskin® at the French Congress of Allergy</h4><p>CFA 2014 - Clinical Abstract<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1372606734.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (142 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/16/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>CFA 2014 &#8211; Clinical Abstract</h4><p>DBV Announces the First reported case of a long term sustained effect of Peanut desensitization after Epicutaneous Immunotherapy (EPIT) with Viaskin® at the French Congress of Allergy<br/><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1372606734.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (142 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/15/2014 | </span><span class='dbv-docs-terms'>Press releases | Quarterly financial information</span><p><h4>DBV Technologies Announces Topline Financial Results   for First Three Months 2014  </h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/982606652_1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (182 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>04/09/2014 | </span><span class='dbv-docs-terms'>Other | Press releases</span><p><h4>DBV Technologies and CEA conclude a scientific cooperation to investigate epigenetic modulation in epicutaneous immunotherapy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1136605663.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (129 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Other|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/07/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Announces Creation of US Subsidiary and Appoints Ms. Susanna Mesa as Vice President of Finance, US Investor Relations &#038; Strategy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1074605064.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (108 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/02/2014 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/13582014_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (16 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>03/31/2014 | </span><span class='dbv-docs-terms'>Press releases | Share buyback Programs</span><p><h4>Additional Contribution to the Liquidity Agreement with Natixis</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1010604156.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (94 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases|Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>03/25/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Announces Data Presentations for EPIT at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2014</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1056603064.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (129 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/17/2014 | </span><span class='dbv-docs-terms'>Annual Financial reports | Press releases | Quarterly financial information</span><p><h4>DBV Technologies Reports Full Year 2013 Financial Results and Provides VIPES Update</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/968601446.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (119 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Annual Financial reports|Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>03/04/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Presentation and Publication of Research at AAAAI Demonstrates EPITTM’s Ability to rebalance the Immune System and Induce a Disease-Modifying Effect</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1202599560.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (113 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/18/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies and Mount Sinai Hospital Enter Research Collaboration for Crohn’s Disease</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1220597090.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (134 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/30/2014 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports Full Year 2013 Topline Financial Results</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1170594238.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (114 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/08/2014 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/9642014_monthly-info-regarding-total-nu.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (16 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2014</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>12/17/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV provides 2013 year-end summary and news flow guidance for 2014</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1208pr_dbv_provides-2013-year-end-summa.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (141 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/13/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Dr. Hugh Sampson presents Epicutaneous Immunotherapy for Food Allergy at the World Allergy Organization Conference</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1322pr_dbv_dr-sampson-presents-epit-for.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (105 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/02/2013 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1030monthly-info-regarding-total-number.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>11/26/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Enters into Collaboration Agreement with BioNetAsia and University of Geneva on Whooping Cough Booster Vaccine</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1260pr_dbv_bionet_geneva-collaboration.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (156 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/14/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies announces the completion of a €29.9m private placement with a majority placed with US investors</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1318dbv-technologies-pricing-press-rele.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (206 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/13/2013 | </span><span class='dbv-docs-terms'>Prospectus</span><p><h4>Update of the 2012 Reference Document</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1024dbv_update-of-2012-ref-document.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (679 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Prospectus</td></tr><tr><td><p><span class='dbv-docs-date'>10/24/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>NIH-sponsored Consortium of Food Allergy Research (CoFAR) starts a Phase II clinical study with DBV Technologies’ Viaskin® Peanut in the treatment of peanut allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1282pr_dbv_cofar6-study.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (117 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/22/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Forms Research Collaboration with Inserm to Develop Viaskin® for Refractory Hemophilia A Disease</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1234pr_dbv_inserm_research_collaboratio.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (119 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/18/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Stallergenes and DBV Technologies Announce Respiratory Allergy Research and Development Collaboration for Birch Pollen</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/970pr_dbv_stallergen_announce-respitato-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (154 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/15/2013 | </span><span class='dbv-docs-terms'>Press releases | Quarterly financial information</span><p><h4>DBV Announces Topline Financial Results for First Nine Months 2013 and Provides Safety Update on Viaskin® Peanut</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1034pr_dbv_q3results-safety-update.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (116 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>10/02/2013 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company September 2013</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/13622013_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>09/05/2013 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company August 2013</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/9782013_monthly-info-regarding-total-nu.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>09/04/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies initiates a long-term follow-up study of Viaskin Peanut</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/946pr_dbv_olfus-vipes.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (94 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>08/06/2013 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company &#8211; July 2013</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/12542013_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>07/26/2013 | </span><span class='dbv-docs-terms'>Half-year financial reports</span><p><h4>DBV Technologies &#8211; 2013 Half Year financial Report</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1284dbv_half-year-financial-report.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (1 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports</td></tr><tr><td><p><span class='dbv-docs-date'>07/08/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies completes enrollment of Phase IIb VIPES study, the first-ever global trial in desensitization to peanut allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1400pr_dbv_completes-enrollment-of-phas.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (141 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/05/2013 | </span><span class='dbv-docs-terms'>Share buyback Programs</span><p><h4>Half year update DBV liquidity agreement</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/11502013-half-year-update-dbv-liquidity.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (145 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>06/28/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies announces breakthrough Data Presentations at EAACI-WAO Congress</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1088pr_dbv_announces-breakthrough-data-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (84 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/20/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Viaskin Peanut demonstrates strong efficacy trend in severely peanut-allergic children in 18-month results of ARACHILD pilot study</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/952pr-ap-hp_dbv-arachild_18-month-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (126 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/10/2013 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/12382013_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>06/04/2013 | </span><span class='dbv-docs-terms'>General meeting | Press releases</span><p><h4>DBV Technologies’ June 4th, 2013 Combined Shareholders’s Meeting</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1422dbv_adoption-of-all-resolutions-sub.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (76 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>General meeting|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/04/2013 | </span><span class='dbv-docs-terms'>General meeting</span><p><h4>Agenda and Text of the resolutions proposed by the Board of Directors</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1258dbv_agenda-and-text-of-resolutions-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (254 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>General meeting</td></tr><tr><td><p><span class='dbv-docs-date'>05/16/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Stallergenes and DBV Technologies enter into partnership for the development of innovative treatment of respiratory allergies</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1352pr_dbv_stallergen-enter-into-partne.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (142 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/07/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies and Mount Sinai Hospital enter into a Research Collaboration Agreement</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1368pr_dbv_mount-sinai-hospital-enter-i.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (93 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/25/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies publishes its 2012 Registration Document and its 2012 Annual Financial Report</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1248pr_dbv_publishes-2012-registration-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (149 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/25/2013 | </span><span class='dbv-docs-terms'>Prospectus</span><p><h4>2012 Reference Document</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/11222012_dbv_reference-document.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (3 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Prospectus</td></tr><tr><td><p><span class='dbv-docs-date'>04/14/2013 | </span><span class='dbv-docs-terms'>Press releases | Quarterly financial information</span><p><h4>DBV Technologies’ first quarter 2013 Topline and cash position</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1346pr_dbv_q1topline.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (77 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>04/02/2013 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company &#8211; March 2013</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/13082013_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>03/05/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies enters into a strategic manufacturing agreement with Sanofi</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1472pr_dbv_sanofi.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (95 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/04/2013 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company February 2013</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/10542013_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>03/04/2013 | </span><span class='dbv-docs-terms'>Half-year financial reports | Press releases</span><p><h4>DBV Technologies reports Full Year 2012 financial results and provides R&#038;D update</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1444pr_dbv_reports-full-year-2012-finan.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (213 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/21/2013 | </span><span class='dbv-docs-terms'>Prospectus</span><p><h4>Update of the registration Document</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1160actualisationva.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (956 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Prospectus</td></tr><tr><td><p><span class='dbv-docs-date'>02/21/2013 | </span><span class='dbv-docs-terms'>Prospectus</span><p><h4>Registration Document</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1304dbv_registration-document.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (4 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Prospectus</td></tr><tr><td><p><span class='dbv-docs-date'>02/01/2013 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company &#8211; January 2013</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/11722013_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>01/31/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Reports Full Year 2012 Topline and Provides an Update on R&#038;D Activities</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/914pr_dbv_reports-full-year-2012-toplin.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (102 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/15/2013 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies and INRA receive funding to develop pediatric bronchiolitis (‘RSV’) vaccine: RSV-NanoViaSkin</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/09/1230pr-anr-dbv-inra-vf_1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (172 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/02/2013 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company December 2012</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/12762013_monthly-info-regarding-total-n.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>01/02/2013 | </span><span class='dbv-docs-terms'>Share buyback Programs</span><p><h4>Half year liquidity contract report</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2018/01/1334pr_dbv_half-year-update-on-dbv-liqu.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (109 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2013</td><td class='dbv-docs-term' style='display:none'>Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>12/18/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies’ 2013 Financial calendar</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1360pr_dbv_financial-calendar2013.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (85 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/05/2012 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company November 2012</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1292monthly-info-regarding-total-number.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>11/14/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies launches its third Viaskin® program, a first for the treatment of House Dust Mites (HDM) allergy in young children</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1156pr-dbv-isi.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (139 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/04/2012 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company October 2012</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/962monthly-info-total-number-of-voting-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>10/16/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies and Centre d&#8217;Immunologie de Marseille-Luminy (CIML) enter in a Collaboration Agreement</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/938cp-inserm_dbv-collaboration_1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (284 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/15/2012 | </span><span class='dbv-docs-terms'>Press releases | Quarterly financial information</span><p><h4>First nine months topline and clinical and business highlights</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/906pr_dbv_q3-topline-final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (131 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases|Quarterly financial information</td></tr><tr><td><p><span class='dbv-docs-date'>10/03/2012 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company &#8211; September 2012</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/988monthly-info-total-number-of-voting-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (20 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>10/03/2012 | </span><span class='dbv-docs-terms'>Outstanding shares and voting rights statements</span><p><h4>Monthly information regarding the total number of voting rights and total number of shares of the Company &#8211; April to August 2012</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1262monthly-info-regarding-total-number.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (22 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Outstanding shares and voting rights statements</td></tr><tr><td><p><span class='dbv-docs-date'>08/02/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies initiates VIPES phase IIb clinical study, the first global trial ever in desensitization of peanut-allergic children and adults</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/954pr_dbv-vipes-first-patient-in-clinic.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (138 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/26/2012 | </span><span class='dbv-docs-terms'>Share buyback Programs</span><p><h4>Half-year update on the liquidity agreement contracted with Natixis</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1040bilan-semestriel-natixis-juillet.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (104 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>07/26/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Half Year 2012 results and R&#038;D highlights: DBV Technologies on track</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1044pr_dbv_half-year-results-and-r-d-hi.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (140 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/26/2012 | </span><span class='dbv-docs-terms'>Half-year financial reports</span><p><h4>2012 Interim financial report</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1214pr_dbv_2012_interim-financial-repor.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Half-year financial reports</td></tr><tr><td><p><span class='dbv-docs-date'>07/19/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies welcomes Mr. Stef Koppelman as its new General Scientific Advisor</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1048pr-stef-kopelman_final.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (120 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/18/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies presents detailed results of a clinical study showing that VIASKIN® is safe and well-tolerated by peanut-allergic patients at the EAACI congress</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1080pr_dbv-presents-results-of-clinical.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (129 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/18/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Positive interim clinical data in peanut allergic children treated with VIASKIN PEANUT</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1128pr_dbv_ap-hp_dbv-eaaci-arachild.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (333 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/06/2012 | </span><span class='dbv-docs-terms'>General meeting | Press releases</span><p><h4>DBV Technologies’ June 6th 2012 Ordinary Meeting of Shareholders</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/10/1290pr-ag-6-6-12.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (114 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>General meeting|Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/31/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Professor Hugh Sampson joins Scientific Advisory Board of DBV Technologies</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1018pr_dbv_sab-pr-sampson.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (124 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/15/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>First quarter 2012 topline, scientific activity and upcoming clinical data</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/994pr_dbv_q1-2012-and-scientific-activi.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (134 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>05/10/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies welcomes Charles Ruban as Chief Development Officer</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1302pr_dbv_cdo-cruban-en.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (114 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/26/2012 | </span><span class='dbv-docs-terms'>Share buyback Programs</span><p><h4>Implementation of a liquidity agreement with Natixis</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/918pr_dbv_mise-en-oeuvre-contrat-natixi.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (119 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Share buyback Programs</td></tr><tr><td><p><span class='dbv-docs-date'>03/28/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Successful Initial Public Offering (IPO) for DBV Technologies</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1232pr_dbv_successful-ipo.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (401 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>03/06/2012 | </span><span class='dbv-docs-terms'>Prospectus</span><p><h4>Update of the Document de Base DBV Technologies</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1008dbv_actualisation_doc-de-base.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (956 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Prospectus</td></tr><tr><td><p><span class='dbv-docs-date'>02/28/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Viaskin Peanut receives FDA “Fast Track Designation”</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1410pr_2012_fda-fast-track-phaseib-vias.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (18 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/31/2012 | </span><span class='dbv-docs-terms'>Prospectus</span><p><h4>Document de Base DBV Technologies &#8211; N° I 12-004</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1440dbv_document-de-base.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (7 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Prospectus</td></tr><tr><td><p><span class='dbv-docs-date'>01/31/2012 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies announces the filing of its “Document de Base” with the French Autorité des marchés financiers</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1006pr_dbv-announces-filing-of-doc-de-b.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (501 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2012</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/06/2011 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies introduces its new Chief Financial Officer</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1244pr_dbv_proudly-welcomes-dshilansky-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (109 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2011</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>09/21/2011 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies moves to Bagneux</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1134pr_dbv_move-into-new-buildings.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (201 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2011</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/08/2011 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies VIASKIN® technology has been chosen to feature on the cover of the European Journal of Allergy and Clinical Immunology June 2011 issue in its timeline “100 years allergen specific immunotherapy.”</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/11662011_european-journal-of-allergy-an.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (2 MB)</a></p></td><td class='dbv-docs-year' style='display:none'>2011</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/18/2011 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies elects George Horner as non­ executive Chairman</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1224pr_dbv_elects-george-horner-as-non-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (181 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2011</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/08/2011 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies is very proud to have been chosen to feature on the cover of the Journal of Allergy and Clinical Immunology January 2011 issue</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1108viaskin-on-cover-of-journal-of-alle.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (692 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2011</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/05/2011 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies closes $25.5 (€19,4) million Series ‘C’ financing round</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1164pr_dbv_closes-25.5-million-series-c.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (107 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2011</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>09/23/2010 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Granted US Patents for Allergen Delivery System VIASKIN®</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1042pr_dbv-granted-us-patents-for-aller-1.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (214 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2010</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>09/01/2010 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>VIASKIN® PEANUT Selected for U.S. Consortium of Food Allergy Research’s Peanut Allergy Desensitization Trial</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1020pr_dbv-viaskin-peanut-selected-for-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (211 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2010</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>07/06/2010 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Receives IND Clearance From FDA to Begin Clinical Trial in Peanut Allergy</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1002pr_dbv_receives-ind-clearance-from-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (207 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2010</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>06/14/2010 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies expands Scientific Advisory Board with appointment of leading US allergy specialists</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1144pr_dbv_expands-sab-with-appointment.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (205 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2010</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>12/18/2009 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies appoints Professor Robert Zeiger to its Scientific Advisory Board</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1332pr_dbv-professeur-robert-zeiger-app.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (208 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2009</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>10/19/2009 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies appoints Professors Gideon Lack and Philippe Eigenmann to its Scientific Advisory Board</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1212pr_dbv-professors-lack-and-eigenman.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (208 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2009</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>04/15/2009 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies signs strategic agreement with Assistance Publique-Hôpitaux de Paris (AP-HP) office of technology transfer and industrial partnerships</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/944pr_dbv-signs-strategic-agreement-wit.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (206 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2009</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>02/19/2009 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies expands its Board of Directors</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1412pr_dbv_expands-its-board-of-directo.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (202 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2009</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/22/2009 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies raises €6 million in Series B investment and secures new corporate investor</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/934151208_dbv_investment-roundv4-clean-.doc' target='_blank' class='dbv-docs-icon'>Download PDF (197 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2009</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>11/13/2007 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>DBV Technologies Strengthens Board of Directors and Scientific Advisory Board</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/900pr_dbv-strengthens-board-of-director.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (211 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2007</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr><tr><td><p><span class='dbv-docs-date'>01/23/2006 | </span><span class='dbv-docs-terms'>Press releases</span><p><h4>Sofinnova and Apax Partners invest €12 million in DBV Technologies</h4><a href='https://www.dbv-technologies.com/wp-content/uploads/2017/12/1324pr_dbv-sofinnova-and-apax-partners-.pdf' target='_blank' class='dbv-docs-icon'>Download PDF (218 KB)</a></p></td><td class='dbv-docs-year' style='display:none'>2006</td><td class='dbv-docs-term' style='display:none'>Press releases</td></tr></tbody></table></div></div>
</div>
            <div class="clearboth"></div>
        </div>


            
            
            
        
        <div class="clearboth"></div>
    </div>
</div>

<div class="mk-main-wrapper-holder">
	<div class="theme-page-wrapper no-padding full-layout mk-grid vc_row-fluid">
		<div class="theme-content no-padding">

			


<div class="clearboth"></div>
	</div> 		</div> 			</div> 

				
<div class="mk-page-section-wrapper">
    <div id="page-section-4" class="mk-page-section self-hosted   full_layout full-width-4 js-el js-master-row    "    data-intro-effect="false">

        
            
            <div class="mk-page-section-inner">
                


<div class="mk-video-color-mask"></div>

                
                            </div>
            
            
        <div class="page-section-content vc_row-fluid mk-grid">
            <div class="mk-padding-wrapper">
<div style="" class="vc_col-sm-12 wpb_column column_container  _ height-full">
	</div>
</div>
            <div class="clearboth"></div>
        </div>


            
            
            
        
        <div class="clearboth"></div>
    </div>
</div>

<div class="mk-main-wrapper-holder">
	<div class="theme-page-wrapper no-padding full-layout mk-grid vc_row-fluid">
		<div class="theme-content no-padding">

			

		<div class="clearboth"></div>
		                      
					  <div class="clearboth"></div>
											  </div>
								<div class="clearboth"></div>

								</div>
			</div>


				
		</div>          

<section id="mk-footer-unfold-spacer"></section>

<section id="mk-footer" class="" role="contentinfo" itemscope="itemscope" itemtype="https://schema.org/WPFooter" >
        <div class="footer-wrapper mk-grid">
        <div class="mk-padding-wrapper">
            		<div class="mk-col-1-4"><section id="media_image-2" class="widget widget_media_image"><img width="257" height="300" src="https://www.dbv-technologies.com/wp-content/uploads/2018/02/dbvtechnologies_logo_4cp-400-x-400-257x300.png" class="image wp-image-9436  attachment-medium size-medium" alt="" style="max-width: 100%; height: auto;" srcset="https://www.dbv-technologies.com/wp-content/uploads/2018/02/dbvtechnologies_logo_4cp-400-x-400-257x300.png 257w, https://www.dbv-technologies.com/wp-content/uploads/2018/02/dbvtechnologies_logo_4cp-400-x-400.png 337w" sizes="(max-width: 257px) 100vw, 257px" itemprop="image" /></section></div>
			<div class="mk-col-1-4"><section id="nav_menu-1" class="widget widget_nav_menu"><div class="menu-footer-left-container"><ul id="menu-footer-left" class="menu">
<li id="menu-item-8928" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-8928"><a href="https://www.dbv-technologies.com/"><svg class="mk-svg-icon" data-name="mk-icon-angle-right" data-cacheid="icon-5dde4df26820f" style=" height:14px; width: 5px; " xmlns="http://www.w3.org/2000/svg" viewbox="0 0 640 1792"><path d="M595 960q0 13-10 23l-466 466q-10 10-23 10t-23-10l-50-50q-10-10-10-23t10-23l393-393-393-393q-10-10-10-23t10-23l50-50q10-10 23-10t23 10l466 466q10 10 10 23z"></path></svg>About Us</a></li>
<li id="menu-item-8370" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8370"><a href="https://www.dbv-technologies.com/leadership/"><svg class="mk-svg-icon" data-name="mk-icon-angle-right" data-cacheid="icon-5dde4df26820f" style=" height:14px; width: 5px; " xmlns="http://www.w3.org/2000/svg" viewbox="0 0 640 1792"><path d="M595 960q0 13-10 23l-466 466q-10 10-23 10t-23-10l-50-50q-10-10-10-23t10-23l393-393-393-393q-10-10-10-23t10-23l50-50q10-10 23-10t23 10l466 466q10 10 10 23z"></path></svg>Leadership</a></li>
<li id="menu-item-8371" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8371"><a href="https://www.dbv-technologies.com/pipeline/"><svg class="mk-svg-icon" data-name="mk-icon-angle-right" data-cacheid="icon-5dde4df26820f" style=" height:14px; width: 5px; " xmlns="http://www.w3.org/2000/svg" viewbox="0 0 640 1792"><path d="M595 960q0 13-10 23l-466 466q-10 10-23 10t-23-10l-50-50q-10-10-10-23t10-23l393-393-393-393q-10-10-10-23t10-23l50-50q10-10 23-10t23 10l466 466q10 10 10 23z"></path></svg>Our Pipeline</a></li>
</ul></div></section></div>
			<div class="mk-col-1-4"><section id="nav_menu-2" class="widget widget_nav_menu"><div class="menu-footer-right-container"><ul id="menu-footer-right" class="menu">
<li id="menu-item-8929" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8929"><a href="https://www.dbv-technologies.com/viaskin-platform/"><svg class="mk-svg-icon" data-name="mk-icon-angle-right" data-cacheid="icon-5dde4df26cc96" style=" height:14px; width: 5px; " xmlns="http://www.w3.org/2000/svg" viewbox="0 0 640 1792"><path d="M595 960q0 13-10 23l-466 466q-10 10-23 10t-23-10l-50-50q-10-10-10-23t10-23l393-393-393-393q-10-10-10-23t10-23l50-50q10-10 23-10t23 10l466 466q10 10 10 23z"></path></svg>Viaskin<sup>®</sup> Platform</a></li>
<li id="menu-item-8373" class="menu-item menu-item-type-post_type menu-item-object-page current-page-ancestor menu-item-8373"><a href="https://www.dbv-technologies.com/investor-relations/"><svg class="mk-svg-icon" data-name="mk-icon-angle-right" data-cacheid="icon-5dde4df26cc96" style=" height:14px; width: 5px; " xmlns="http://www.w3.org/2000/svg" viewbox="0 0 640 1792"><path d="M595 960q0 13-10 23l-466 466q-10 10-23 10t-23-10l-50-50q-10-10-10-23t10-23l393-393-393-393q-10-10-10-23t10-23l50-50q10-10 23-10t23 10l466 466q10 10 10 23z"></path></svg>Investors &amp; Media</a></li>
<li id="menu-item-8374" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8374"><a href="https://www.dbv-technologies.com/contact-us/"><svg class="mk-svg-icon" data-name="mk-icon-angle-right" data-cacheid="icon-5dde4df26cc96" style=" height:14px; width: 5px; " xmlns="http://www.w3.org/2000/svg" viewbox="0 0 640 1792"><path d="M595 960q0 13-10 23l-466 466q-10 10-23 10t-23-10l-50-50q-10-10-10-23t10-23l393-393-393-393q-10-10-10-23t10-23l50-50q10-10 23-10t23 10l466 466q10 10 10 23z"></path></svg>Contact Us</a></li>
</ul></div></section></div>
			<div class="mk-col-1-4"><section id="social-2" class="widget widget_social_networks"><div class="widgettitle">Follow Us</div><div id="social-5dde4df26d289" class="align-left"><a href="https://www.facebook.com/DBV-Technologies-222890957906209/timeline/" rel="nofollow" class="builtin-icons mk-square-pointed custom medium facebook-hover" target="_blank" alt=" facebook" title=" facebook"><svg  class="mk-svg-icon" data-name="mk-jupiter-icon-simple-facebook" data-cacheid="icon-5dde4df26d413" style=" height:12px; width: 12px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M192.191 92.743v60.485h-63.638v96.181h63.637v256.135h97.069v-256.135h84.168s6.674-51.322 9.885-96.508h-93.666v-42.921c0-8.807 11.565-20.661 23.01-20.661h71.791v-95.719h-83.57c-111.317 0-108.686 86.262-108.686 99.142z"/></svg></a><a href="https://www.linkedin.com/company/dbv-technologies" rel="nofollow" class="builtin-icons mk-square-pointed custom medium linkedin-hover" target="_blank" alt=" linkedin" title=" linkedin"><svg  class="mk-svg-icon" data-name="mk-jupiter-icon-simple-linkedin" data-cacheid="icon-5dde4df26d5fc" style=" height:12px; width: 12px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M80.111 25.6c-29.028 0-48.023 20.547-48.023 47.545 0 26.424 18.459 47.584 46.893 47.584h.573c29.601 0 47.999-21.16 47.999-47.584-.543-26.998-18.398-47.545-47.442-47.545zm-48.111 128h96v320.99h-96v-320.99zm323.631-7.822c-58.274 0-84.318 32.947-98.883 55.996v1.094h-.726c.211-.357.485-.713.726-1.094v-48.031h-96.748c1.477 31.819 0 320.847 0 320.847h96.748v-171.241c0-10.129.742-20.207 3.633-27.468 7.928-20.224 25.965-41.185 56.305-41.185 39.705 0 67.576 31.057 67.576 76.611v163.283h97.717v-176.313c0-104.053-54.123-152.499-126.347-152.499z"/></svg></a><a href="https://twitter.com/dbvtechnologies" rel="nofollow" class="builtin-icons mk-square-pointed custom medium twitter-hover" target="_blank" alt=" twitter" title=" twitter"><svg  class="mk-svg-icon" data-name="mk-jupiter-icon-simple-twitter" data-cacheid="icon-5dde4df26d7fb" style=" height:12px; width: 12px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path d="M454.058 213.822c28.724-2.382 48.193-15.423 55.683-33.132-10.365 6.373-42.524 13.301-60.269 6.681-.877-4.162-1.835-8.132-2.792-11.706-13.527-49.679-59.846-89.698-108.382-84.865 3.916-1.589 7.914-3.053 11.885-4.388 5.325-1.923 36.678-7.003 31.749-18.079-4.176-9.728-42.471 7.352-49.672 9.597 9.501-3.581 25.26-9.735 26.93-20.667-14.569 1.991-28.901 8.885-39.937 18.908 3.998-4.293 7.01-9.536 7.666-15.171-38.91 24.85-61.624 74.932-80.025 123.523-14.438-13.972-27.239-25.008-38.712-31.114-32.209-17.285-70.722-35.303-131.156-57.736-1.862 19.996 9.899 46.591 43.723 64.273-7.325-.986-20.736 1.219-31.462 3.773 4.382 22.912 18.627 41.805 57.251 50.918-17.642 1.163-26.767 5.182-35.036 13.841 8.043 15.923 27.656 34.709 62.931 30.82-39.225 16.935-15.998 48.234 15.93 43.565-54.444 56.244-140.294 52.123-189.596 5.08 128.712 175.385 408.493 103.724 450.21-65.225 31.23.261 49.605-10.823 60.994-23.05-17.99 3.053-44.072-.095-57.914-5.846z"/></svg></a>
					<style>
						#social-5dde4df26d289 a { 
							opacity: 1 !important;margin: 3px;color: #72d5e7 !important;border-color: #ffffff !important;background-color: #ffffff !important;}
						#social-5dde4df26d289 a:hover { color: #72d5e7 !important;background-color: #a1e8f8 !important;}
						#social-5dde4df26d289 a:hover .mk-svg-icon { fill: #72d5e7 !important;}</style></div></section></div>
	            <div class="clearboth"></div>
        </div>
    </div>
        
<div id="sub-footer">
	<div class=" mk-grid">
		
    	<span class="mk-footer-copyright">© 2018 DBV Technologies. All rights reserved.</span>
    	<nav id="mk-footer-navigation" class="footer_menu"><ul id="menu-sub-footer-menu" class="menu"><li id="menu-item-9095" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-9095"><a href="/..">DBV Technologies therapies are investigational and not FDA approved.</a></li>
<li id="menu-item-8367" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-8367"><a href="https://www.dbv-technologies.com/terms-of-use/">Terms of Use</a></li>
</ul></nav>	</div>
	<div class="clearboth"></div>
</div>
</section>
</div>
</div>

<div class="bottom-corner-btns js-bottom-corner-btns">

<a href="#top-of-page" class="mk-go-top  js-smooth-scroll js-bottom-corner-btn js-bottom-corner-btn--back">
	<svg  class="mk-svg-icon" data-name="mk-icon-chevron-up" data-cacheid="icon-5dde4df272448" style=" height:16px; width: 16px; "  xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1792 1792"><path d="M1683 1331l-166 165q-19 19-45 19t-45-19l-531-531-531 531q-19 19-45 19t-45-19l-166-165q-19-19-19-45.5t19-45.5l742-741q19-19 45-19t45 19l742 741q19 19 19 45.5t-19 45.5z"/></svg></a>
</div>




    <style type='text/css'></style>		<script>
		( function ( body ) {
			'use strict';
			body.className = body.className.replace( /\btribe-no-js\b/, 'tribe-js' );
		} )( document.body );
		</script>
		<script type="text/javascript">
    php = {
        hasAdminbar: false,
        json: (null != null) ? null : "",
        jsPath: 'https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/js'
      };
    </script><script> /* <![CDATA[ */var tribe_l10n_datatables = {"aria":{"sort_ascending":": activate to sort column ascending","sort_descending":": activate to sort column descending"},"length_menu":"Show _MENU_ entries","empty_table":"No data available in table","info":"Showing _START_ to _END_ of _TOTAL_ entries","info_empty":"Showing 0 to 0 of 0 entries","info_filtered":"(filtered from _MAX_ total entries)","zero_records":"No matching records found","search":"Search:","all_selected_text":"All items on this page were selected. ","select_all_link":"Select all pages","clear_selection":"Clear Selection.","pagination":{"all":"All","next":"Next","previous":"Previous"},"select":{"rows":{"0":"","_":": Selected %d rows","1":": Selected 1 row"}},"datepicker":{"dayNames":["Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday"],"dayNamesShort":["Sun","Mon","Tue","Wed","Thu","Fri","Sat"],"dayNamesMin":["S","M","T","W","T","F","S"],"monthNames":["January","February","March","April","May","June","July","August","September","October","November","December"],"monthNamesShort":["January","February","March","April","May","June","July","August","September","October","November","December"],"monthNamesMin":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"nextText":"Next","prevText":"Prev","currentText":"Today","closeText":"Done","today":"Today","clear":"Clear"}};var tribe_system_info = {"sysinfo_optin_nonce":"bec54c1d58","clipboard_btn_text":"Copy to clipboard","clipboard_copied_text":"System info copied","clipboard_fail_text":"Press \"Cmd + C\" to copy"};/* ]]> */ </script><script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/the-events-calendar/common/vendor/datatables/datatables.min.js?ver=4.8.2'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/js/core-scripts.js?ver=4.9.12'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/js/components-full.js?ver=4.9.12'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/themes/jupiter/assets/js/plugins/wp-enqueue/smoothscroll.js?ver=4.9.12'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-includes/js/wp-embed.min.js?ver=4.9.12'></script>
<script type='text/javascript' src='https://www.dbv-technologies.com/wp-content/plugins/js_composer_theme/assets/js/dist/js_composer_front.min.js?ver=5.1.1'></script>
		<script type="text/javascript">
				</script>
	<script type="text/javascript">	window.get = {};	window.get.captcha = function(enteredCaptcha) {
                  return jQuery.get(ajaxurl, { action : "mk_validate_captcha_input", captcha: enteredCaptcha });
              	};</script><style id="mk-shortcode-dynamic-styles" type="text/css">#fancy-title-3{letter-spacing:0px;text-transform:initial;font-size:14px;color:;text-align:left;font-style:inherit;font-weight:inherit;padding-top:0px;padding-bottom:20px;}#fancy-title-3 span{} @media handheld, only screen and (max-width:767px) { #fancy-title-3 { text-align:center !important; } } .full-width-2 { min-height:100px; margin-bottom:40px; } .full-width-2 .page-section-content { padding:40px 0 0px; } #background-layer--2 { background-color:;; background-position:center top; background-repeat:no-repeat; ; } #background-layer--2 .mk-color-layer { background-color:;; width:100%; height:100%; position:absolute; top:0; left:0; } .full-width-4 { min-height:100px; margin-bottom:0px; } .full-width-4 .page-section-content { padding:40px 0 40px; } #background-layer--4 { ; background-position:left top; background-repeat:repeat; ; } #background-layer--4 .mk-color-layer { ; width:100%; height:100%; position:absolute; top:0; left:0; }</style>	
</body>
</html>